Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
ACTN2,Alpha-actinin-2,Lifestyle factors,X1050.Time spend outdoors in summer,44952,0.0565457577195395,0.021214798884182,0.0149647519065428,0.0981267635325362,0.00769571670334231
ACTN2,Alpha-actinin-2,Lifestyle factors,X1060.Time spent outdoors in winter,41818,0.0950006506904742,0.0242248431930162,0.0475199580321624,0.142481343348786,8.82822232979048e-05
ACTN2,Alpha-actinin-2,Physical activities,X1070.Time spent watching television (TV),45974,-0.0607890991010013,0.021002989368078,-0.101954958262434,-0.0196232399395683,0.00380367888603684
ACTN2,Alpha-actinin-2,Physical activities,X1080.Time spent using computer,41782,-0.113078312095703,0.0225588193880271,-0.157293598096236,-0.06886302609517,5.42117449242425e-07
ACTN2,Alpha-actinin-2,Physical activities,X1090.Time spent driving,40855,-0.0622957437325546,0.0237405731366834,-0.108827267080454,-0.0157642203846551,0.0086976306528583
ACTN2,Alpha-actinin-2,Lifestyle factors,X1160.Sleep duration,47480,-0.0374965019034689,0.0198387627846589,-0.0763804769614003,0.0013874731544625,0.0587618320222057
ACTN2,Alpha-actinin-2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32424,0.0122393556310019,0.0213131732409616,-0.0295344639212828,0.0540131751832867,0.565805280232394
ACTN2,Alpha-actinin-2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32424,-0.036167575615847,0.0209984796020063,-0.0773245956357794,0.00498944440408543,0.0850349610470311
ACTN2,Alpha-actinin-2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32424,-0.00639535728454664,0.0243356931040106,-0.0540933157684074,0.0413026011993141,0.792713048207555
ACTN2,Alpha-actinin-2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32424,0.0264353625628539,0.0253408119946249,-0.0232326289466108,0.0761033540723187,0.296888271799949
ACTN2,Alpha-actinin-2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32424,-0.0358172331446008,0.0258892032733978,-0.0865600715604606,0.0149256052712589,0.166553344078098
ACTN2,Alpha-actinin-2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32424,-0.0359715588622679,0.0495019972942582,-0.132995473559014,0.0610523558344782,0.467448708374562
ACTN2,Alpha-actinin-2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32424,0.008906148421493,0.0505907694318233,-0.0902517596648807,0.108064056507867,0.860264360488641
ACTN2,Alpha-actinin-2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32424,-0.030775588674664,0.0363923531465347,-0.102104600841872,0.0405534234925441,0.397765589812842
ACTN2,Alpha-actinin-2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32424,-0.0162223365389668,0.0271494868672484,-0.0694353307987736,0.03699065772084,0.550176667338193
ACTN2,Alpha-actinin-2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32424,-0.0345684049711272,0.018980784369981,-0.07177074233629,0.0026339323940356,0.0686065266968142
ACTN2,Alpha-actinin-2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32424,-0.0109587947459981,0.0269066324893172,-0.0636957944250598,0.0417782049330636,0.683805393657411
ACTN2,Alpha-actinin-2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32424,0.00869421740776571,0.0154021767332632,-0.0214940489894303,0.0388824838049617,0.572442437521532
ACTN2,Alpha-actinin-2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32424,-0.0285768125204041,0.0197138796460567,-0.0672160166266753,0.010062391585867,0.147212763011855
ACTN2,Alpha-actinin-2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32424,-0.0159258313778539,0.0298133081008462,-0.0743599152555124,0.0425082524998046,0.593227193949088
ACTN2,Alpha-actinin-2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32424,-0.0413764607566611,0.027791433484321,-0.0958476703859303,0.0130947488726081,0.136571418297387
ACTN2,Alpha-actinin-2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32424,-0.0234508334271999,0.0342728649063208,-0.0906256486435888,0.0437239817891889,0.493842725520833
ACTN2,Alpha-actinin-2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32424,-0.0429436267171793,0.033347780957689,-0.10830527739425,0.0224180239598911,0.197867570950283
ACTN2,Alpha-actinin-2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32424,-0.0106153603452322,0.0219979155070616,-0.0537312747390728,0.0325005540486085,0.62941902750156
ACTN2,Alpha-actinin-2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32424,-0.0129080346169355,0.0206914355309101,-0.0534632482575192,0.0276471790236482,0.532752791210881
ACTN2,Alpha-actinin-2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32424,0.00588211992539542,0.0256234961860896,-0.0443399325993403,0.0561041724501311,0.818439473351348
ACTN2,Alpha-actinin-2,Health and medical history,X120040.Fatigue severity over the past week,32433,-0.0114673494141798,0.0345294355030514,-0.0791450430001605,0.056210344171801,0.73981916197011
ACTN2,Alpha-actinin-2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32435,-0.00802147950434855,0.0343070855499384,-0.0752633671822279,0.0592204081735308,0.815134904309454
ACTN2,Alpha-actinin-2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32433,0.0697634804424301,0.0371677940197515,-0.00308539583628276,0.142612356721143,0.060553764345432
ACTN2,Alpha-actinin-2,Health and medical history,X120098.Mobility problems today,32437,0.045991926065115,0.0413795447336572,-0.0351119816128531,0.127095833743083,0.266399304735528
ACTN2,Alpha-actinin-2,Health and medical history,X120099.Self-care problems today,32437,0.051305575439773,0.0626924691521831,-0.0715716640985059,0.174182814978052,0.413169240973743
ACTN2,Alpha-actinin-2,Health and medical history,X120100.Problems doing usual activities,32437,0.0470670477303018,0.0390557662251048,-0.0294822540709035,0.123616349531507,0.228188631803605
ACTN2,Alpha-actinin-2,Health and medical history,X120101.Pain or discomfort today,32437,-0.0132016904829203,0.0342410905717997,-0.0803142280036477,0.0539108470378071,0.699838712057089
ACTN2,Alpha-actinin-2,Health and medical history,X120102.Anxiety or depression today,32437,-0.00668266301858896,0.0408576019809579,-0.0867635629012664,0.0733982368640885,0.87008151349649
ACTN2,Alpha-actinin-2,Health and medical history,X120103.Scale to indicate how health is today,32406,0.00437222214173128,0.00662251421534361,-0.00860790572034219,0.0173523500038047,0.509139578894828
ACTN2,Alpha-actinin-2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32421,0.00730741265919733,0.0406573385752323,-0.072380970948258,0.0869957962666527,0.857367458829699
ACTN2,Alpha-actinin-2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32407,0.0202760198976155,0.0415253348986093,-0.0611136365036587,0.10166567629889,0.62536355411374
ACTN2,Alpha-actinin-2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32426,-0.0174142067449359,0.0339562686381119,-0.0839684932756352,0.0491400797857635,0.608074950948182
ACTN2,Alpha-actinin-2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32429,-0.0175324941129851,0.0347827471399952,-0.0857066785073758,0.0506416902814056,0.614234144547006
ACTN2,Alpha-actinin-2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32423,0.0136983086382218,0.0426241581628809,-0.0698450413610248,0.0972416586374683,0.747934608392886
ACTN2,Alpha-actinin-2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32404,-0.0121742943142901,0.043550929096948,-0.0975341153443081,0.0731855267157279,0.779836022585262
ACTN2,Alpha-actinin-2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32429,0.00160675410161711,0.0433710433035157,-0.0834004907732737,0.086613998976508,0.970448631905649
ACTN2,Alpha-actinin-2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32418,-0.069217393628545,0.0675695626342857,-0.201653736391745,0.0632189491346549,0.305681396406607
ACTN2,Alpha-actinin-2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32374,-0.0788467677273154,0.0893289067779089,-0.253931425012017,0.0962378895573861,0.377446651048799
ACTN2,Alpha-actinin-2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",29978,-0.0211633155449151,0.0449235605615331,-0.10921349424552,0.0668868631556899,0.637588890540615
ACTN2,Alpha-actinin-2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,44842,0.0107155919396495,0.04660478101308,-0.0806297788459873,0.102060962725286,0.818152496627661
ACTN2,Alpha-actinin-2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43714,-0.00780807356141849,0.0282191018695562,-0.0631175132257487,0.0475013661029117,0.782017486667865
ACTN2,Alpha-actinin-2,Diet and food preferences,X1289.Cooked vegetable intake,46618,0.055291121089823,0.0205668315354438,0.0149801312803532,0.0956021108992929,0.00718554286326426
ACTN2,Alpha-actinin-2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46177,0.0629332120524856,0.0219131982354377,0.0199833435110277,0.105883080593944,0.00408355131994379
ACTN2,Alpha-actinin-2,Diet and food preferences,X1309.Fresh fruit intake,46615,0.129490267783575,0.021677652089435,0.0870020696882821,0.171978465878867,2.35746222987812e-09
ACTN2,Alpha-actinin-2,Diet and food preferences,X1319.Dried fruit intake,45305,0.0502426136791555,0.0228946206456003,0.00536915721377883,0.0951160701445322,0.0282090130015739
ACTN2,Alpha-actinin-2,Health and medical history,X134.Number of self-reported cancers,47678,0.0221524395780696,0.0459777204789517,-0.0679638925606758,0.112268771716815,0.62994668006462
ACTN2,Alpha-actinin-2,Health and medical history,X135.Number of self-reported non-cancer illnesses,47678,0.041252144218413,0.0199411996346322,0.00216739293453389,0.080336895502292,0.0385860268144605
ACTN2,Alpha-actinin-2,Health and medical history,"X136.Number of operations, self-reported",47678,0.0170988556643334,0.0198324943126664,-0.0217728331884928,0.0559705445171596,0.388606150645552
ACTN2,Alpha-actinin-2,Health and medical history,X137.Number of treatments or medications taken,47678,0.064880243857564,0.019857476537112,0.0259595898448244,0.103800897870304,0.00108733928469433
ACTN2,Alpha-actinin-2,Diet and food preferences,X1438.Bread intake,46935,-0.00321224322997116,0.00421191779747677,-0.0114676021130256,0.00504311565308331,0.445676536586326
ACTN2,Alpha-actinin-2,Diet and food preferences,X1458.Cereal intake,46261,0.0583684588068207,0.0203601939746512,0.0184624786165045,0.098274438997137,0.0041504082019718
ACTN2,Alpha-actinin-2,Diet and food preferences,X1488.Tea intake,46739,0.00901967575252898,0.00398819005147168,0.00120282325164449,0.0168365282534135,0.0237317039504817
ACTN2,Alpha-actinin-2,Diet and food preferences,X1498.Coffee intake,45734,0.0138626921781392,0.0204098110308234,-0.0261405374422747,0.0538659217985531,0.497007515983016
ACTN2,Alpha-actinin-2,Diet and food preferences,X1528.Water intake,46011,0.12202169971069,0.0214033435558481,0.0800711463412271,0.163972253080152,1.20580229326545e-08
ACTN2,Alpha-actinin-2,Lifestyle factors,X1568.Average weekly red wine intake,39970,0.000643628776739697,0.023768520666257,-0.045942671729124,0.0472299292826034,0.978397025874448
ACTN2,Alpha-actinin-2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,39965,-0.0117742928824831,0.0244367574070811,-0.059670337400362,0.0361217516353957,0.629935297030764
ACTN2,Alpha-actinin-2,Lifestyle factors,X1588.Average weekly beer plus cider intake,40006,-0.0331485832883982,0.0262905545914658,-0.0846780702876711,0.0183809037108747,0.207379230323285
ACTN2,Alpha-actinin-2,Lifestyle factors,X1598.Average weekly spirits intake,39942,0.0271582264778718,0.0266030215643235,-0.0249836957882022,0.0793001487439459,0.307331394246856
ACTN2,Alpha-actinin-2,Lifestyle factors,X1608.Average weekly fortified wine intake,40000,0.0480020940243775,0.0480754660161355,-0.0462258193672481,0.142230007416003,0.318064624800798
ACTN2,Alpha-actinin-2,Lifestyle factors,X1737.Childhood sunburn occasions,42171,-0.0710401786688609,0.0240147372935085,-0.118109063764138,-0.0239712935735843,0.00309845887241195
ACTN2,Alpha-actinin-2,Health and medical history,X1807.Father's age at death,38101,-0.00429998776720348,0.00549578363010924,-0.0150717236822176,0.00647174814781062,0.433983279528328
ACTN2,Alpha-actinin-2,Health and medical history,X1845.Mother's age,37438,-0.000412873041593664,0.00868089159865641,-0.0174274205749602,0.0166016744917729,0.962066707661295
ACTN2,Alpha-actinin-2,Health and medical history,X1873.Number of full brothers,47252,0.0182639272308241,0.0199375098351264,-0.0208135920460237,0.0573414465076718,0.359645607217136
ACTN2,Alpha-actinin-2,Health and medical history,X1883.Number of full sisters,47251,0.00251664912245554,0.0197845064361191,-0.0362609834923379,0.041294281737249,0.898780802460724
ACTN2,Alpha-actinin-2,Physical measures,X20015.Sitting height,47480,0.0101285661767441,0.00529566583504027,-0.000250938859934864,0.020508071213423,0.0558095291100094
ACTN2,Alpha-actinin-2,Cognitive function,X20016.Fluid intelligence score,31425,-0.106368155752689,0.0319101603620301,-0.168912070062268,-0.0438242414431105,0.000862155787873699
ACTN2,Alpha-actinin-2,Cognitive function,X20018.Prospective memory result,31720,0.0323938192038795,0.0443342012985682,-0.0545012153413141,0.119288853749073,0.465000481224849
ACTN2,Alpha-actinin-2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31361,0.00446485635421027,0.00771521636723672,-0.0106569677255737,0.0195866804339942,0.562803686952189
ACTN2,Alpha-actinin-2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31363,0.00779726981274568,0.00768795765673719,-0.00727112719445921,0.0228656668199506,0.310511149194329
ACTN2,Alpha-actinin-2,Cognitive function,X20023.Mean time to correctly identify matches,47404,0.00282305216088858,0.00422349866311457,-0.00545500521881598,0.0111011095405932,0.503874928184955
ACTN2,Alpha-actinin-2,Health and medical history,X20107#1.Illnesses of father_Heart disease,44932,-0.00716478030854861,0.00911441114598768,-0.0250290261546845,0.0106994655375873,0.431821490378657
ACTN2,Alpha-actinin-2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44562,0.00453589614590094,0.0208208967079671,-0.0362730614017146,0.0453448536935165,0.827545745287369
ACTN2,Alpha-actinin-2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44535,-0.0287291698312103,0.0278280681241246,-0.0832721833544946,0.0258138436920739,0.301905727697016
ACTN2,Alpha-actinin-2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44561,-0.020987766961211,0.0210953764377385,-0.0623347047791784,0.0203591708567564,0.319797063442861
ACTN2,Alpha-actinin-2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44564,-0.00644838373890155,0.0155618630877734,-0.0369496353909374,0.0240528679131343,0.678606765184619
ACTN2,Alpha-actinin-2,Health and medical history,X20107#2.Illnesses of father_Stroke,44698,-0.000406497571864,0.0119958891072562,-0.0239184402220861,0.0231054450783581,0.972968057749086
ACTN2,Alpha-actinin-2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44651,-0.0222678053656356,0.0156053412622665,-0.052854274239678,0.00831866350840675,0.153613690119561
ACTN2,Alpha-actinin-2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44566,0.0256352076223682,0.0187870644827183,-0.0111874387637595,0.062457854008496,0.172420761525895
ACTN2,Alpha-actinin-2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44673,-0.00811082962628896,0.0148634800508904,-0.0372432505260341,0.0210215912734562,0.585285949994208
ACTN2,Alpha-actinin-2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44792,0.00363368494714224,0.00944828442906867,-0.0148849525338323,0.0221523224281168,0.700547523778082
ACTN2,Alpha-actinin-2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44666,0.0178061862689548,0.0128542723971937,-0.00738818762954477,0.0430005601674544,0.16599551423186
ACTN2,Alpha-actinin-2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45807,-0.00837950135954083,0.0109381493406955,-0.029818274067304,0.0130592713482223,0.44363672875221
ACTN2,Alpha-actinin-2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45701,-0.0112078700234369,0.017742448624355,-0.0459830693271727,0.023567329280299,0.527590820334824
ACTN2,Alpha-actinin-2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45651,-0.0224947825131726,0.0375682738273718,-0.0961285992148213,0.051139034188476,0.549332011690999
ACTN2,Alpha-actinin-2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45690,-0.0111047315777736,0.0159263917079626,-0.0423204593253802,0.0201109961698331,0.485651618993491
ACTN2,Alpha-actinin-2,Health and medical history,X20110#2.Illnesses of mother_Stroke,45754,0.00568313909032321,0.0130112547953059,-0.0198189203084763,0.0311851984891227,0.662270573294267
ACTN2,Alpha-actinin-2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45696,-0.0121283499001216,0.0212562033469059,-0.0537905084600572,0.029533808659814,0.568290715985607
ACTN2,Alpha-actinin-2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45673,0.00638031478763893,0.0199950991306212,-0.0328100795083786,0.0455707090836565,0.749658340955015
ACTN2,Alpha-actinin-2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45703,0.0161813590978514,0.0152072792895647,-0.0136249083096954,0.0459876265053983,0.287316216404868
ACTN2,Alpha-actinin-2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45711,-0.00188536566063549,0.0178999953069415,-0.0369693564622407,0.0331986251409698,0.916116736182626
ACTN2,Alpha-actinin-2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45900,-0.00145627070549807,0.00861422644275504,-0.018340154533298,0.0154276131223018,0.865755602318493
ACTN2,Alpha-actinin-2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45755,0.0189618135706164,0.0133069353211872,-0.00711977965891055,0.0450434068001433,0.154183821235795
ACTN2,Alpha-actinin-2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43416,0.00539551098224284,0.0176063148085327,-0.0291128660424813,0.039903888006967,0.75926289315817
ACTN2,Alpha-actinin-2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43320,-0.0500963810090062,0.0992376944969965,-0.244602262223119,0.144409500205107,0.613696588931394
ACTN2,Alpha-actinin-2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43319,0.0254390721496782,0.0833147251069625,-0.137857789059968,0.188735933359325,0.760112728611482
ACTN2,Alpha-actinin-2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43395,0.008447382418021,0.0162434562217841,-0.0233897917766759,0.0402845566127179,0.603035777383673
ACTN2,Alpha-actinin-2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43323,0.0258988191065596,0.0555747007231773,-0.083027594310868,0.134825232523987,0.641207725576076
ACTN2,Alpha-actinin-2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43338,-0.00322135557298264,0.0303207306762848,-0.0626499876985009,0.0562072765525356,0.915390905876599
ACTN2,Alpha-actinin-2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43322,0.0807181920037397,0.039673801933806,0.00295754021347992,0.158478843793999,0.0419100603394921
ACTN2,Alpha-actinin-2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43335,-0.0323502633501768,0.0362445710374393,-0.103389622583558,0.0386890958832041,0.372106699068578
ACTN2,Alpha-actinin-2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43335,0.00099845976537501,0.0241501016694151,-0.0463357395066786,0.0483326590374286,0.967022147208046
ACTN2,Alpha-actinin-2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43342,-0.00812419053354672,0.0321011066185255,-0.0710423595058567,0.0547939784387632,0.800208041519616
ACTN2,Alpha-actinin-2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43492,0.00750018746045859,0.0113541718581094,-0.0147539893814358,0.029754364302353,0.508898002133543
ACTN2,Alpha-actinin-2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43399,0.0403599497292005,0.0165466029837624,0.00792860788102627,0.0727912915773748,0.0147299466076409
ACTN2,Alpha-actinin-2,Mental health,X20127.Neuroticism score,42959,-0.0140731852060761,0.0205506993670702,-0.0543525559655336,0.0262061855533814,0.493476414823696
ACTN2,Alpha-actinin-2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31425,-0.10603136927375,0.0323133851870237,-0.169365604240316,-0.0426971343071832,0.0010378199073984
ACTN2,Alpha-actinin-2,Lifestyle factors,X20161.Pack years of smoking,30534,-0.0122266956880161,0.00842059404657045,-0.0287310600192942,0.00427766864326197,0.146548838423027
ACTN2,Alpha-actinin-2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30534,-0.0104688658772734,0.00787227693133424,-0.0258985286626885,0.00496079690814169,0.18361656026051
ACTN2,Alpha-actinin-2,Cognitive function,X20191.Fluid intelligence score,29966,-0.0951473534644545,0.0369677468916031,-0.167604137371997,-0.0226905695569124,0.0100824384345482
ACTN2,Alpha-actinin-2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,29966,-0.0600342259519311,0.0376983640282213,-0.133923019447245,0.0138545675433826,0.11132676144258
ACTN2,Alpha-actinin-2,Cognitive function,X20240.Maximum digits remembered correctly,29433,0.00541224261140712,0.0393863075696608,-0.0717849202251281,0.0826094054479424,0.890708285107762
ACTN2,Alpha-actinin-2,Physical measures,X20255.Spirometry QC measure,41555,0.0129377492783131,0.0263320975727026,-0.0386731619641841,0.0645486605208102,0.623199163940892
ACTN2,Alpha-actinin-2,Eye measures,X20261.avMSE,29061,-0.00516161121512715,0.00968825305848973,-0.024150587209767,0.0138273647795127,0.594215519149401
ACTN2,Alpha-actinin-2,Eye measures,X20262.Myopia diagnosis,29061,0.0199941535905953,0.0458122519478666,-0.0697978602272232,0.109786167408414,0.662537948399095
ACTN2,Alpha-actinin-2,NMR metabolomics,X20280.Glucose-lactate,36992,-0.00690877581610886,0.00548048750099133,-0.0176505313180519,0.00383297968583415,0.207470576863619
ACTN2,Alpha-actinin-2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37017,-0.0514525376928026,0.00539550707183524,-0.0620277315535997,-0.0408773438320056,1.73872701874759e-21
ACTN2,Alpha-actinin-2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31268,0.00711255784207588,0.0258069502586751,-0.0434690646649273,0.0576941803490791,0.782858164340987
ACTN2,Alpha-actinin-2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31266,0.118024041294815,0.0524008449229555,0.0153183852458217,0.220729697343807,0.0243305320258508
ACTN2,Alpha-actinin-2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31267,0.00379350020925124,0.0582900465714529,-0.110454991070796,0.118041991489299,0.948112279472566
ACTN2,Alpha-actinin-2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31267,-0.00123583679598975,0.0249680369697487,-0.0501731892566972,0.0477015156647177,0.960524758132336
ACTN2,Alpha-actinin-2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31267,-0.00553047614399221,0.0400814522545158,-0.0840901225628432,0.0730291702748588,0.890259237975105
ACTN2,Alpha-actinin-2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31271,-0.0350257355482894,0.0517691623779044,-0.136493293808982,0.0664418227124033,0.498696582614028
ACTN2,Alpha-actinin-2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31271,-0.0498277605238622,0.0348902139592027,-0.1182125798839,0.0185570588361752,0.15329658905611
ACTN2,Alpha-actinin-2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31271,-0.0369172163359904,0.0374384772291798,-0.110296631705183,0.0364621990332019,0.324127585783807
ACTN2,Alpha-actinin-2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31271,-0.0379444600031193,0.057964638539135,-0.151555151539824,0.0756662315335853,0.512736666005498
ACTN2,Alpha-actinin-2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31271,-0.00646869186861671,0.0668509566463168,-0.137496566895398,0.124559183158164,0.922917310335968
ACTN2,Alpha-actinin-2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31271,-0.0465148778503904,0.0391717397765306,-0.12329148781239,0.0302617321116095,0.23508424560008
ACTN2,Alpha-actinin-2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31271,-0.105334984492294,0.0660831388227237,-0.234857936584832,0.0241879676002445,0.110983894132924
ACTN2,Alpha-actinin-2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31271,-0.0651299761213186,0.0489550603227897,-0.161081894353986,0.0308219421113491,0.183426348003474
ACTN2,Alpha-actinin-2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31274,0.0301720841472357,0.0676091784733607,-0.102341905660551,0.162686073955023,0.655413803426776
ACTN2,Alpha-actinin-2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31274,0.00791920588586913,0.0334642369371727,-0.0576706985109894,0.0735091102827277,0.812937317628546
ACTN2,Alpha-actinin-2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31274,-0.00836179869268843,0.0459369702779127,-0.0983982604373972,0.0816746630520204,0.855566004205992
ACTN2,Alpha-actinin-2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31274,-0.0754761958912545,0.0771715519491619,-0.226732437711612,0.0757800459291029,0.328090738309581
ACTN2,Alpha-actinin-2,Diet and food preferences,X20600.Liking for adding salt to foods,33170,-0.00653180719444013,0.0300299781860943,-0.0653905644391849,0.0523269500503047,0.82781603253206
ACTN2,Alpha-actinin-2,Diet and food preferences,X20601.Liking for aniseed,33170,0.00832359827720707,0.0300321711136944,-0.050539457105634,0.0671866536600481,0.781666435253187
ACTN2,Alpha-actinin-2,Diet and food preferences,X20602.Liking for apple juice,33170,-0.000498960954430422,0.0298113800723022,-0.0589292658961427,0.0579313439872818,0.98664657751561
ACTN2,Alpha-actinin-2,Diet and food preferences,X20603.Liking for apples,33170,0.0317504389719529,0.0303029490708938,-0.0276433412069989,0.0911442191509047,0.294773060144389
ACTN2,Alpha-actinin-2,Diet and food preferences,X20604.Liking for asparagus,33170,-0.0104832357176943,0.0304785435624585,-0.0702211811001129,0.0492547096647243,0.730888193165419
ACTN2,Alpha-actinin-2,Diet and food preferences,X20605.Liking for aubergine,33170,0.0257791437338237,0.0304058703204234,-0.0338163620942061,0.0853746495618535,0.39655200236288
ACTN2,Alpha-actinin-2,Diet and food preferences,X20606.Liking for avocados,33170,0.0154521921353788,0.0307810621704963,-0.0448786897187939,0.0757830739895515,0.615677143487356
ACTN2,Alpha-actinin-2,Diet and food preferences,X20607.Liking for bacon,33170,0.00491090355825809,0.0304510338055852,-0.054773122700689,0.0645949298172052,0.871882563377332
ACTN2,Alpha-actinin-2,Diet and food preferences,X20608.Liking for baked or steamed fish,33170,0.0726659437471112,0.0305272152924417,0.0128326017739254,0.132499285720297,0.0173154773170572
ACTN2,Alpha-actinin-2,Diet and food preferences,X20609.Liking for bananas,33170,0.0591563396155319,0.0308222846368535,-0.00125533827270096,0.119568017503765,0.0549805166030839
ACTN2,Alpha-actinin-2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33170,0.0410278199143992,0.0299934841703297,-0.0177594090594471,0.0998150488882454,0.171379214520268
ACTN2,Alpha-actinin-2,Diet and food preferences,X20611.Liking for beef steak,33170,0.0352582550636594,0.0304378745518873,-0.0243999790580397,0.0949164891853585,0.246743698244095
ACTN2,Alpha-actinin-2,Diet and food preferences,X20612.Liking for beetroot,33170,0.00487623921218846,0.0308883514107467,-0.0556649295528752,0.0654174079772521,0.874565339337385
ACTN2,Alpha-actinin-2,Diet and food preferences,X20613.Liking for bell pepper,33170,-0.000699747239628626,0.0303651466566837,-0.0602154346867286,0.0588159402074713,0.981615333421994
ACTN2,Alpha-actinin-2,Diet and food preferences,X20614.Liking for bicycling,33170,0.139111077181331,0.0302235731638411,0.0798728737802027,0.19834928058246,4.22505194110396e-06
ACTN2,Alpha-actinin-2,Diet and food preferences,X20615.Liking for biscuits,33170,-0.0421288672966384,0.029867063583733,-0.100668311920755,0.0164105773274783,0.158411964118034
ACTN2,Alpha-actinin-2,Diet and food preferences,X20616.Liking for bitter foods,33170,-0.00225583950494606,0.0298809947345505,-0.060822589184665,0.0563109101747729,0.939823196647088
ACTN2,Alpha-actinin-2,Diet and food preferences,X20617.Liking for bitter or ale,33170,-0.0203880445131582,0.0305019364088984,-0.0801718398745989,0.0393957508482826,0.50388337128945
ACTN2,Alpha-actinin-2,Diet and food preferences,X20618.Liking for black olives,33170,0.0114421177597943,0.0300793857637658,-0.0475134783371866,0.0703977138567752,0.703659189659433
ACTN2,Alpha-actinin-2,Diet and food preferences,X20619.Liking for black pepper,33170,0.0296304648648621,0.0305122571576815,-0.0301735591641937,0.0894344888939179,0.331523541597295
ACTN2,Alpha-actinin-2,Diet and food preferences,X20620.Liking for blue cheese,33170,0.0160207142055426,0.0298648802196283,-0.0425144510249289,0.0745558794360142,0.591667371881627
ACTN2,Alpha-actinin-2,Diet and food preferences,X20621.Liking for bolognese sauce,33170,0.00259885136448699,0.0303532059669667,-0.0568934323307677,0.0620911350597417,0.931770083550501
ACTN2,Alpha-actinin-2,Diet and food preferences,X20622.Liking for broad beans,33170,0.0219461958621435,0.0302085936361071,-0.0372626476646263,0.0811550393889134,0.46755763728221
ACTN2,Alpha-actinin-2,Diet and food preferences,X20623.Liking for broccoli,33170,0.111453481286421,0.0309292111931174,0.0508322273479113,0.172074735224932,0.000315597812899168
ACTN2,Alpha-actinin-2,Diet and food preferences,X20624.Liking for brown rice,33170,0.0359772506273262,0.0301134162001757,-0.0230450451250182,0.0949995463796706,0.2322249629234
ACTN2,Alpha-actinin-2,Diet and food preferences,X20625.Liking for brussel sprouts,33170,0.0175957960650685,0.0302449021258924,-0.0416842121016806,0.0768758042318176,0.560730827732944
ACTN2,Alpha-actinin-2,Diet and food preferences,X20626.Liking for burgers (meat),33170,-0.00190310835298178,0.0298901920232773,-0.0604878847186053,0.0566816680126417,0.949234365626968
ACTN2,Alpha-actinin-2,Diet and food preferences,X20627.Liking for burn of spicy foods,33170,0.00208817144787366,0.0302161900195064,-0.0571355609903588,0.0613119038861061,0.94490537618239
ACTN2,Alpha-actinin-2,Diet and food preferences,X20628.Liking for butter on bread,33170,0.0286485271179112,0.0303943240026568,-0.0309243479272962,0.0882214021631186,0.345929595072546
ACTN2,Alpha-actinin-2,Diet and food preferences,X20629.Liking for butternut squash,33170,0.0340215460439234,0.0300668819806337,-0.0249095426381187,0.0929526347259655,0.257861717498857
ACTN2,Alpha-actinin-2,Diet and food preferences,X20630.Liking for cabbage,33170,0.0469589460900981,0.0302910686333596,-0.0124115484312867,0.106329440611483,0.121113828150487
ACTN2,Alpha-actinin-2,Diet and food preferences,X20631.Liking for cake,33170,-0.0352487977241216,0.0301719225359862,-0.0943857658946546,0.0238881704464113,0.242729877490104
ACTN2,Alpha-actinin-2,Diet and food preferences,X20632.Liking for cake icing,33170,-0.0108120225447362,0.0294251869018506,-0.0684853888723634,0.0468613437828909,0.713298391771368
ACTN2,Alpha-actinin-2,Diet and food preferences,X20633.Liking for capers,33170,-0.00975003277679863,0.0302117229286486,-0.0689650097169498,0.0494649441633526,0.746911912091976
ACTN2,Alpha-actinin-2,Diet and food preferences,X20634.Liking for cauliflower,33170,0.0353930025360309,0.0306065318817808,-0.0245957999522595,0.0953818050243213,0.247552504438705
ACTN2,Alpha-actinin-2,Diet and food preferences,X20635.Liking for cereal or granola bar,33170,0.0366395722012252,0.0298767278947066,-0.0219188144723997,0.09519795887485,0.220094929769837
ACTN2,Alpha-actinin-2,Diet and food preferences,X20636.Liking for cheesecake,33170,-0.0183049039133916,0.0300145266349434,-0.0771333761178808,0.0405235682910975,0.54196404926669
ACTN2,Alpha-actinin-2,Diet and food preferences,X20637.Liking for cherries,33170,0.065690895939064,0.0312094205859455,0.00452043159061088,0.126861360287517,0.0353318273299706
ACTN2,Alpha-actinin-2,Diet and food preferences,X20638.Liking for chicken,33170,0.0363963103178366,0.0314992365793649,-0.0253421933777185,0.0981348140133918,0.247929155222051
ACTN2,Alpha-actinin-2,Diet and food preferences,X20639.Liking for chilli pepper,33170,-0.0214677038452711,0.0300916519989249,-0.0804473417631639,0.0375119340726216,0.475609608218809
ACTN2,Alpha-actinin-2,Diet and food preferences,X20640.Liking for chips or french fries,33170,-0.0849857571530217,0.0306201530560188,-0.145001257142819,-0.0249702571632249,0.0055229652995926
ACTN2,Alpha-actinin-2,Diet and food preferences,X20641.Liking for cigarette smoking,33170,-0.0220817998183735,0.0476109240862981,-0.115399211027518,0.0712356113907708,0.642804105867064
ACTN2,Alpha-actinin-2,Diet and food preferences,X20642.Liking for cod,33170,0.0296833809659189,0.0310282448798962,-0.0311319789986776,0.0904987409305154,0.338765381803001
ACTN2,Alpha-actinin-2,Diet and food preferences,X20643.Liking for coffee with sugar,33170,-0.00990122858256803,0.0327266572897046,-0.074045476870389,0.0542430197052529,0.762244749571853
ACTN2,Alpha-actinin-2,Diet and food preferences,X20644.Liking for coffee without sugar,33170,0.0177118572730773,0.0305071978465073,-0.042082250506077,0.0775059650522316,0.561537878177918
ACTN2,Alpha-actinin-2,Diet and food preferences,X20645.Liking for coriander,33170,0.0667764620304033,0.0300216660282038,0.00793399661512388,0.125618927445683,0.0261538124345053
ACTN2,Alpha-actinin-2,Diet and food preferences,X20646.Liking for corn flakes,33170,-0.0268894105462343,0.029970584183803,-0.0856317555464883,0.0318529344540196,0.369638944376433
ACTN2,Alpha-actinin-2,Diet and food preferences,X20647.Liking for cream,33170,0.00680322548214886,0.0304623132855161,-0.0529029085574627,0.0665093595217604,0.823281616225991
ACTN2,Alpha-actinin-2,Diet and food preferences,X20648.Liking for croissant,33170,-0.0308977355673047,0.030020553411975,-0.0897380202547756,0.0279425491201663,0.303403357774075
ACTN2,Alpha-actinin-2,Diet and food preferences,X20649.Liking for cucumber,33170,0.00429747417130662,0.0304918934159779,-0.0554666369240101,0.0640615852666233,0.887921774795578
ACTN2,Alpha-actinin-2,Diet and food preferences,X20650.Liking for curry,33170,0.0244617084424221,0.0306423442097392,-0.0355972862086668,0.0845207030935109,0.424718218836477
ACTN2,Alpha-actinin-2,Diet and food preferences,X20651.Liking for dairy products,33170,0.108851822485917,0.0305766613369777,0.0489215662654409,0.168782078706393,0.000372756148062299
ACTN2,Alpha-actinin-2,Diet and food preferences,X20652.Liking for dark chocolate,33170,-0.00221673347023348,0.0303346496254857,-0.0616726467361855,0.0572391797957186,0.941747247513019
ACTN2,Alpha-actinin-2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33170,-0.0516089744978719,0.0308070115546901,-0.111990717145064,0.00877276814932067,0.0939218085562857
ACTN2,Alpha-actinin-2,Diet and food preferences,X20654.Liking for dried fruit,33170,0.0597582301378922,0.0302277060346656,0.000511926309947494,0.119004533965837,0.0480783890631348
ACTN2,Alpha-actinin-2,Diet and food preferences,X20655.Liking for eggs,33170,0.0622003705076516,0.0311051479671002,0.00123428049213517,0.123166460523168,0.0455637633841661
ACTN2,Alpha-actinin-2,Diet and food preferences,X20656.Liking for exercising alone,33170,0.134798400389931,0.0303611003492424,0.0752906437054157,0.194306157074446,9.10646270642403e-06
ACTN2,Alpha-actinin-2,Diet and food preferences,X20657.Liking for exercising with others,33170,0.153161858885902,0.0304844997236365,0.0934122394275741,0.212911478344229,5.14795627674664e-07
ACTN2,Alpha-actinin-2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33170,0.0344877887983558,0.0307833586842786,-0.0258475942228302,0.0948231718195418,0.262598373520025
ACTN2,Alpha-actinin-2,Diet and food preferences,X20659.Liking for fatty foods,33170,-0.0277671944599723,0.0300144541599723,-0.0865955246135179,0.0310611356935734,0.354923634463046
ACTN2,Alpha-actinin-2,Diet and food preferences,X20660.Liking for fresh tomatoes,33170,0.0449452501630042,0.0324150239782219,-0.0185881968343107,0.108478697160319,0.165610386241601
ACTN2,Alpha-actinin-2,Diet and food preferences,X20661.Liking for fried chicken,33170,-0.0346530233557647,0.0299387168542252,-0.0933329083900461,0.0240268616785167,0.247112065956475
ACTN2,Alpha-actinin-2,Diet and food preferences,X20662.Liking for fried or battered fish,33170,-0.0128621731362012,0.0299799608223561,-0.0716228963480192,0.0458985500756168,0.66791447151791
ACTN2,Alpha-actinin-2,Diet and food preferences,X20663.Liking for fruit,33170,0.113923852097778,0.0334313665144247,0.0483983737295051,0.17944933046605,0.000657921303907028
ACTN2,Alpha-actinin-2,Diet and food preferences,X20664.Liking for garlic,33170,0.0148902545667592,0.0305858861495351,-0.0450580822863296,0.0748385914198479,0.626387323378916
ACTN2,Alpha-actinin-2,Diet and food preferences,X20665.Liking for gherkins,33170,0.00108568262887237,0.0296761933250823,-0.057079656288289,0.0592510215460337,0.970817250552448
ACTN2,Alpha-actinin-2,Diet and food preferences,X20666.Liking for globe artichoke,33170,-0.0146717222971861,0.0305578897002537,-0.0745651861096833,0.0452217415153111,0.631147116024529
ACTN2,Alpha-actinin-2,Diet and food preferences,X20667.Liking for goat's cheese,33170,0.0477130206948656,0.0297580510844196,-0.0106127594305969,0.106038800820328,0.108888025308998
ACTN2,Alpha-actinin-2,Diet and food preferences,X20668.Liking for going to a cafe,33170,-0.0334862242489432,0.0301591814902206,-0.0925982199697755,0.0256257714718891,0.266891548727578
ACTN2,Alpha-actinin-2,Diet and food preferences,X20669.Liking for going to the gym,33170,0.128373605298665,0.0301767082762373,0.0692272570772402,0.18751995352009,2.11982317161488e-05
ACTN2,Alpha-actinin-2,Diet and food preferences,X20670.Liking for going to the pub,33170,-0.0267687709569023,0.0302551567080581,-0.0860688781046963,0.0325313361908917,0.376305062545324
ACTN2,Alpha-actinin-2,Diet and food preferences,X20671.Liking for grapefruit,33170,-0.004198678123295,0.0301307823466329,-0.0632550115226956,0.0548576552761056,0.889177814779278
ACTN2,Alpha-actinin-2,Diet and food preferences,X20672.Liking for green olives,33170,0.019427354870993,0.030222286139597,-0.0398083259626172,0.0786630357046032,0.520359650694945
ACTN2,Alpha-actinin-2,Diet and food preferences,X20673.Liking for haddock,33170,0.0418869829368025,0.030505863233757,-0.0179045090013611,0.101678474874966,0.169760657354673
ACTN2,Alpha-actinin-2,Diet and food preferences,X20674.Liking for ham,33170,-0.0146829086751155,0.0297817418974023,-0.0730551227940241,0.043689305443793,0.622012128441771
ACTN2,Alpha-actinin-2,Diet and food preferences,X20675.Liking for hard cheese,33170,0.0164052191393299,0.031181749251151,-0.044711009392926,0.0775214476715859,0.598820113165006
ACTN2,Alpha-actinin-2,Diet and food preferences,X20676.Liking for herring,33170,0.0513875154670652,0.0301891383364482,-0.00778319567237323,0.110558226606504,0.0887540048201685
ACTN2,Alpha-actinin-2,Diet and food preferences,X20677.Liking for honey,33170,0.0455639545886336,0.0301396332636422,-0.0135097266081052,0.104637635785372,0.130628373718486
ACTN2,Alpha-actinin-2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33170,-0.0356130862799559,0.0302370200861954,-0.0948776456488989,0.0236514730889871,0.238907485581145
ACTN2,Alpha-actinin-2,Diet and food preferences,X20679.Liking for ice cream,33170,-0.00844994922964431,0.0303846154328225,-0.0680037954779765,0.0511038970186879,0.780942088672035
ACTN2,Alpha-actinin-2,Diet and food preferences,X20680.Liking for jam,33170,0.012692515530102,0.0300040366124088,-0.0461153962302193,0.0715004272904233,0.67228539237288
ACTN2,Alpha-actinin-2,Diet and food preferences,X20681.Liking for kiwi fruit,33170,0.0601328951399858,0.0301373375454745,0.00106371355085574,0.119202076729116,0.0460397772347732
ACTN2,Alpha-actinin-2,Diet and food preferences,X20682.Liking for lager,33170,-0.0470149889723224,0.0298424390565381,-0.105506169523137,0.0114761915784922,0.115188798392946
ACTN2,Alpha-actinin-2,Diet and food preferences,X20683.Liking for lamb,33170,0.0274997856914658,0.0301051889570707,-0.0315063846643929,0.0865059560473244,0.361026089191452
ACTN2,Alpha-actinin-2,Diet and food preferences,X20684.Liking for lemons,33170,0.00232609961344059,0.030599879676272,-0.0576496645520526,0.0623018637789338,0.939407505655328
ACTN2,Alpha-actinin-2,Diet and food preferences,X20685.Liking for lentils or beans,33170,0.00273546139895828,0.0307529821907561,-0.0575403836949237,0.0630113064928403,0.92912398481543
ACTN2,Alpha-actinin-2,Diet and food preferences,X20686.Liking for liver,33170,0.00936935504896581,0.0299205942722503,-0.0492750097246448,0.0680137198225765,0.754180809972652
ACTN2,Alpha-actinin-2,Diet and food preferences,X20687.Liking for mackerel,33170,0.0174459801747854,0.0304303536811309,-0.042197513040231,0.0770894733898019,0.56644969723419
ACTN2,Alpha-actinin-2,Diet and food preferences,X20688.Liking for marzipan,33170,0.0733327351775554,0.0301888115114256,0.0141626646151611,0.13250280573995,0.0151536586484694
ACTN2,Alpha-actinin-2,Diet and food preferences,X20689.Liking for mayonnaise,33170,0.0124933856209496,0.0299823085671437,-0.0462719391706521,0.0712587104125513,0.676913383497876
ACTN2,Alpha-actinin-2,Diet and food preferences,X20690.Liking for melon,33170,0.00423465817721115,0.03139298753933,-0.0572955973998756,0.0657649137542979,0.892700301977047
ACTN2,Alpha-actinin-2,Diet and food preferences,X20691.Liking for milk chocolate,33170,-0.00402040918334389,0.0302002898830448,-0.0632129773541117,0.0551721589874239,0.894097519334735
ACTN2,Alpha-actinin-2,Diet and food preferences,X20692.Liking for mushrooms,33170,0.0234500028902834,0.0311998445066183,-0.0377016923426885,0.0846016981232553,0.452306809322703
ACTN2,Alpha-actinin-2,Diet and food preferences,X20694.Liking for orange juice,33170,-0.0365222536292654,0.0300589343077696,-0.0954377648724937,0.0223932576139629,0.224388706371634
ACTN2,Alpha-actinin-2,Diet and food preferences,X20695.Liking for oranges,33170,0.0382705502766898,0.0306805398035395,-0.0218633077382476,0.0984044082916273,0.212286514600647
ACTN2,Alpha-actinin-2,Diet and food preferences,X20696.Liking for pasta,33170,-0.0558263366947919,0.0306634524578563,-0.11592670351219,0.0042740301226064,0.0686975433000165
ACTN2,Alpha-actinin-2,Diet and food preferences,X20697.Liking for pears,33170,0.0374244958899659,0.0308973714149399,-0.0231343520833163,0.0979833438632482,0.225829699883165
ACTN2,Alpha-actinin-2,Diet and food preferences,X20698.Liking for pizza,33170,-0.0589164121339287,0.0302347621736123,-0.118176545994209,0.000343721726351408,0.0513694677446681
ACTN2,Alpha-actinin-2,Diet and food preferences,X20699.Liking for plain yogurt,33170,0.0979850598947011,0.0300809067741383,0.03902648261739,0.156943637172012,0.00112847427767464
ACTN2,Alpha-actinin-2,Diet and food preferences,X20700.Liking for plums,33170,0.0733639833702821,0.0308723659785876,0.0128541460522504,0.133873820688314,0.0175043233929866
ACTN2,Alpha-actinin-2,Diet and food preferences,X20701.Liking for pollock,33170,0.0178165312640494,0.0303670039679645,-0.0417027965131611,0.0773358590412598,0.557414801000363
ACTN2,Alpha-actinin-2,Diet and food preferences,X20702.Liking for pork chop,33170,0.00863554511707012,0.0298574568204477,-0.0498850702510073,0.0671561604851476,0.7724150798574
ACTN2,Alpha-actinin-2,Diet and food preferences,X20703.Liking for porridge,33170,0.082815313415541,0.0308892122750609,0.0222724573564216,0.14335816947466,0.00735224980442294
ACTN2,Alpha-actinin-2,Diet and food preferences,X20704.Liking for potato crisps,33170,-0.0594524183718713,0.0302858874707939,-0.118812757814627,-9.20789291151344e-05,0.0496712445171644
ACTN2,Alpha-actinin-2,Diet and food preferences,X20705.Liking for potatoes,33170,8.96748701472919e-05,0.0305604595700175,-0.059808825887087,0.0599881756273816,0.997658799319474
ACTN2,Alpha-actinin-2,Diet and food preferences,X20706.Liking for prawns,33170,0.00227542405065969,0.0305130187097722,-0.0575300926204939,0.0620809407218133,0.940556668278654
ACTN2,Alpha-actinin-2,Diet and food preferences,X20707.Liking for raw carrots,33170,0.0624627747741596,0.030489892858767,0.00270258477097617,0.122222964777343,0.0405254617592636
ACTN2,Alpha-actinin-2,Diet and food preferences,X20708.Liking for red meat,33170,0.0279535481963811,0.0299197279027078,-0.0306891184929262,0.0865962148856884,0.35018123635054
ACTN2,Alpha-actinin-2,Diet and food preferences,X20709.Liking for red wine,33170,-0.0320227459831911,0.0304465483253551,-0.0916979807008871,0.0276524887345049,0.292932714196775
ACTN2,Alpha-actinin-2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33170,-0.0564491384868611,0.0309037500316679,-0.11702048854893,0.00412221157520797,0.0677902710887651
ACTN2,Alpha-actinin-2,Diet and food preferences,X20711.Liking for roast chicken,33170,0.0311551690031219,0.0316005129126372,-0.030781836305647,0.0930921743118908,0.324204364354616
ACTN2,Alpha-actinin-2,Diet and food preferences,X20712.Liking for salad dressing,33170,0.035180223776903,0.0301699187366477,-0.0239528169469265,0.0943132645007325,0.243616223367446
ACTN2,Alpha-actinin-2,Diet and food preferences,X20713.Liking for salad leaves,33170,0.0849380245305282,0.0312851428491513,0.0236191445461917,0.146256904514865,0.00664053663725196
ACTN2,Alpha-actinin-2,Diet and food preferences,X20714.Liking for salami,33170,-0.00363280318648311,0.0302846406949959,-0.062990698948675,0.0557250925757088,0.904521147791475
ACTN2,Alpha-actinin-2,Diet and food preferences,X20715.Liking for salmon,33170,0.066638138378974,0.0313885447573982,0.00511659065447357,0.128159686103474,0.0337794994551632
ACTN2,Alpha-actinin-2,Diet and food preferences,X20716.Liking for salty foods,33170,-0.00980190233779493,0.0296431435629268,-0.0679024637211314,0.0482986590455415,0.740906206919045
ACTN2,Alpha-actinin-2,Diet and food preferences,X20717.Liking for salty pretzels,33170,-0.0759357725452695,0.0303970441874848,-0.13551397915274,-0.0163575659377994,0.0125021630256823
ACTN2,Alpha-actinin-2,Diet and food preferences,X20718.Liking for sardines,33170,0.0672565517302516,0.0305971974083623,0.00728604480986144,0.127227058650642,0.0279645462497549
ACTN2,Alpha-actinin-2,Diet and food preferences,X20719.Liking for sausages (meat),33170,0.0165234921762073,0.0301700014087124,-0.042609710584869,0.0756566949372835,0.583925112467482
ACTN2,Alpha-actinin-2,Diet and food preferences,X20720.Liking for savoury biscuits,33170,-0.0447733589716181,0.0301055744945583,-0.103780284980952,0.0142335670377161,0.136992837066027
ACTN2,Alpha-actinin-2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33170,-0.0160376514235374,0.0301831584570062,-0.0751966419992695,0.0431213391521947,0.595192849727781
ACTN2,Alpha-actinin-2,Diet and food preferences,X20722.Liking for skimmed milk,33170,-0.00761054929356733,0.0300943969002672,-0.0665955672180911,0.0513744686309565,0.800359389783223
ACTN2,Alpha-actinin-2,Diet and food preferences,X20723.Liking for smoked fish,33170,0.0309367285841213,0.0304856077508351,-0.0288150626075155,0.0906885197757581,0.310228605401288
ACTN2,Alpha-actinin-2,Diet and food preferences,X20724.Liking for soft cheese,33170,0.00220854622210125,0.0303631705459195,-0.0573032680479009,0.0617203604921034,0.942016437139556
ACTN2,Alpha-actinin-2,Diet and food preferences,X20725.Liking for soy sauce,33170,-0.0666789466815139,0.0303877676571761,-0.126238971289579,-0.00711892207344884,0.0282406961280257
ACTN2,Alpha-actinin-2,Diet and food preferences,X20726.Liking for soya milk,33170,-0.0339289864853501,0.0302030179984064,-0.0931269017622267,0.0252689287915265,0.2613118795835
ACTN2,Alpha-actinin-2,Diet and food preferences,X20727.Liking for spicy foods,33170,0.0157843482565862,0.0303528971614293,-0.0437073301798151,0.0752760266929876,0.603056623240766
ACTN2,Alpha-actinin-2,Diet and food preferences,X20728.Liking for spinach,33170,0.0530561878470861,0.0305197723818599,-0.00676256602135929,0.112874941715532,0.0821698970248675
ACTN2,Alpha-actinin-2,Diet and food preferences,X20729.Liking for spirits,33170,0.00597382484140306,0.0301296455667936,-0.0530802804695123,0.0650279301523185,0.842837635787767
ACTN2,Alpha-actinin-2,Diet and food preferences,X20730.Liking for strawberries,33170,0.0521285026702145,0.0326498562444534,-0.0118652155689141,0.116122220909343,0.110390632551342
ACTN2,Alpha-actinin-2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33170,-0.00860243392098251,0.0307806826289608,-0.0689325718737456,0.0517277040317806,0.779886469434509
ACTN2,Alpha-actinin-2,Diet and food preferences,X20732.Liking for sweet foods,33170,-0.0281724701310105,0.0300143919534307,-0.0870006783597347,0.0306557380977136,0.347944067073625
ACTN2,Alpha-actinin-2,Diet and food preferences,X20733.Liking for taking the stairs,33170,0.105842701442824,0.0312069947473904,0.0446769917379385,0.167008411147709,0.000697665740139927
ACTN2,Alpha-actinin-2,Diet and food preferences,X20734.Liking for tea with sugar,33170,-0.0257846644400442,0.0363604244844811,-0.0970510964296271,0.0454817675495387,0.478254813723634
ACTN2,Alpha-actinin-2,Diet and food preferences,X20735.Liking for tea without sugar,33170,0.0307030481739398,0.0313459561824118,-0.0307350259435874,0.092141122291467,0.327363441784422
ACTN2,Alpha-actinin-2,Diet and food preferences,X20736.Liking for tomato ketchup,33170,-0.0271962020089075,0.030164497985381,-0.0863186180602543,0.0319262140424392,0.36729466352243
ACTN2,Alpha-actinin-2,Diet and food preferences,X20737.Liking for tinned tuna,33170,0.00868595002821551,0.0299986502436843,-0.0501114044494058,0.0674833045058368,0.7721710362058
ACTN2,Alpha-actinin-2,Diet and food preferences,X20738.Liking for turnip (white),33170,-0.0337914217798664,0.0299170037647003,-0.0924287491586789,0.0248459055989461,0.258713758719586
ACTN2,Alpha-actinin-2,Diet and food preferences,X20739.Liking for vegetables,33170,0.115003390735517,0.0337147062356959,0.0489225665135536,0.181084214957481,0.000649825931878424
ACTN2,Alpha-actinin-2,Diet and food preferences,X20740.Liking for vinegar,33170,-0.0329246923750796,0.0300511610159822,-0.0918249679664046,0.0259755832162455,0.273272900900647
ACTN2,Alpha-actinin-2,Diet and food preferences,X20741.Liking for watching television,33170,-0.0222358157032759,0.0298565181339045,-0.0807545912457287,0.036282959839177,0.456438163169689
ACTN2,Alpha-actinin-2,Diet and food preferences,X20742.Liking for whisky,33170,-0.0202212470216499,0.0310710726360584,-0.0811205493883244,0.0406780553450246,0.515187667606806
ACTN2,Alpha-actinin-2,Diet and food preferences,X20743.Liking for white bread,33170,-0.0780550930046355,0.0305733077686004,-0.137978776231092,-0.0181314097781787,0.0106943294120949
ACTN2,Alpha-actinin-2,Diet and food preferences,X20744.Liking for white rice,33170,-0.0385838594222128,0.030516366447733,-0.0983959376597694,0.0212282188153438,0.206130334710942
ACTN2,Alpha-actinin-2,Diet and food preferences,X20745.Liking for white wine,33170,0.00280013304749668,0.0301398999725656,-0.056274070898732,0.0618743369937254,0.925981412966988
ACTN2,Alpha-actinin-2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33170,0.0674340646774225,0.0306374132635435,0.00738473468087727,0.127483394673968,0.0277579195517281
ACTN2,Alpha-actinin-2,Diet and food preferences,X20747.Liking for whole milk,33170,0.0629123689290922,0.029771338817905,0.0045605448459985,0.121264193012186,0.0346114354666319
ACTN2,Alpha-actinin-2,Diet and food preferences,X20748.Liking for wholemeal bread,33170,0.0728423850649754,0.0313762722615851,0.0113448914322686,0.134339878697682,0.0202772986065701
ACTN2,Alpha-actinin-2,Diet and food preferences,X20749.Liking for working up a sweat,33170,0.15678773799068,0.030510359865086,0.096987432655111,0.216588043326248,2.82059868850523e-07
ACTN2,Alpha-actinin-2,Physical measures,X21001.Body mass index (BMI),47564,0.00813779701480773,0.01653931605053,-0.024279262444231,0.0405548564738465,0.622704515697502
ACTN2,Alpha-actinin-2,Physical measures,X21002.Weight,47582,0.0675523454790853,0.00973343156846755,0.0484748196048889,0.0866298713532817,4.01514847486061e-12
ACTN2,Alpha-actinin-2,Physical measures,X21021.Pulse wave Arterial Stiffness index,31652,-0.0117836493778602,0.0080396065198504,-0.027541278156767,0.00397397940104659,0.142770448642035
ACTN2,Alpha-actinin-2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32706,-0.0206827961413466,0.0320221561644887,-0.0834462222237445,0.0420806299410513,0.518367244518032
ACTN2,Alpha-actinin-2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32706,0.0140665622043506,0.0338163012093114,-0.0522133881658997,0.0803465125746008,0.677442149727364
ACTN2,Alpha-actinin-2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32707,0.042868925200793,0.0331031920180654,-0.0220133311546152,0.107751181556201,0.195350996393019
ACTN2,Alpha-actinin-2,Health and medical history,X21040.Satisfaction with bowel habits,32679,-0.0184255258970072,0.0311595659399228,-0.0794982751392559,0.0426472233452415,0.554315798574237
ACTN2,Alpha-actinin-2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32680,-0.0305730998794302,0.0329220009933301,-0.0951002218263573,0.0339540220674969,0.35309462249444
ACTN2,Alpha-actinin-2,Health and medical history,X21042.Greatest number of times bowels opened per day,32671,0.00501934176201408,0.0333685324651611,-0.0603829818697016,0.0704216653937298,0.880435592902552
ACTN2,Alpha-actinin-2,Health and medical history,X21043.Least number of times bowels opened per week,32619,0.104655423216469,0.0333759657736728,0.03923853030007,0.170072316132867,0.00172039752494684
ACTN2,Alpha-actinin-2,Health and medical history,X21044.Average number of times bowels opened per day,32653,0.0533082277251246,0.0360878491741614,-0.0174239566562317,0.124040412106481,0.139663397794839
ACTN2,Alpha-actinin-2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32711,-0.00168405101517546,0.0333578857204859,-0.0670655070273279,0.063697404996977,0.959737563584795
ACTN2,Alpha-actinin-2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32705,-0.00471353044313502,0.0335759370290591,-0.0705223670200908,0.0610953061338208,0.888359652272188
ACTN2,Alpha-actinin-2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29045,-0.0468338676807085,0.052683714464398,-0.150093948030929,0.0564262126695117,0.374064265023655
ACTN2,Alpha-actinin-2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32708,0.0490836490359073,0.0357996726385892,-0.0210837093357275,0.119251007407542,0.170389725427599
ACTN2,Alpha-actinin-2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32706,0.0659847501608116,0.0507845961331618,-0.0335530582601856,0.165522558581809,0.193872668313689
ACTN2,Alpha-actinin-2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32709,0.0700088776839091,0.0409321447336785,-0.0102181259941008,0.150235881361919,0.0872335911552703
ACTN2,Alpha-actinin-2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32707,0.0191248006897999,0.0983644929847714,-0.173669605560352,0.211919206939952,0.845845319258449
ACTN2,Alpha-actinin-2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32710,0.0540000911507082,0.0386008299870133,-0.0216575356238379,0.129657717925254,0.161867220472163
ACTN2,Alpha-actinin-2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32709,0.0143430153769872,0.0393227598782719,-0.0627295939844258,0.0914156247384002,0.715306013866166
ACTN2,Alpha-actinin-2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32491,0.0310256462632039,0.0343550258184897,-0.0363102043410358,0.0983614968674437,0.366503864976596
ACTN2,Alpha-actinin-2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32709,0.0283094274422208,0.0348641077739473,-0.040024223794716,0.0966430786791575,0.416817229473387
ACTN2,Alpha-actinin-2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32710,0.0778090187627006,0.0498288972423123,-0.0198556198322314,0.175473657357633,0.118435926289654
ACTN2,Alpha-actinin-2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32709,0.0313229896680073,0.0330288151902249,-0.0334134881048335,0.0960594674408481,0.342975467234712
ACTN2,Alpha-actinin-2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32708,-0.0120635288147902,0.0330905878264802,-0.0769210809546914,0.052794023325111,0.71544804723396
ACTN2,Alpha-actinin-2,Working and living environment,X21100.Water hardness (USGS classification),47368,0.0298861737164172,0.020366760338097,-0.0100326765462529,0.0698050239790872,0.142280792602164
ACTN2,Alpha-actinin-2,Lifestyle factors,X2139.Age first had sexual intercourse,45035,-0.00295925197754764,0.00450178600624985,-0.0117827525497973,0.00586424859470207,0.510962617679136
ACTN2,Alpha-actinin-2,Health and medical history,X2149.Lifetime number of sexual partners,43339,0.0218598554622275,0.0229698161035481,-0.0231609841007268,0.0668806950251818,0.341272410062493
ACTN2,Alpha-actinin-2,Physical activities,X22032.IPAQ activity group,43330,0.270401432638711,0.0228100996716491,0.225693637282279,0.315109227995143,2.63548816122939e-32
ACTN2,Alpha-actinin-2,Physical activities,X22033.Summed days activity,43817,0.0525059741172685,0.00435646977854252,0.0439672933513252,0.0610446548832119,2.45914758608519e-33
ACTN2,Alpha-actinin-2,Physical activities,X22034.Summed minutes activity,43330,0.0503021015905633,0.00441104010648213,0.0416564629818583,0.0589477401992683,4.99176928704391e-30
ACTN2,Alpha-actinin-2,Physical activities,X22037.MET minutes per week for walking,42671,0.029653368022064,0.0043370761370745,0.021152698793398,0.03815403725073,8.32459265514481e-12
ACTN2,Alpha-actinin-2,Physical activities,X22038.MET minutes per week for moderate activity,43330,0.0508515734318096,0.00453099864207982,0.0419708160933331,0.059732330770286,3.86194130165819e-29
ACTN2,Alpha-actinin-2,Physical activities,X22039.MET minutes per week for vigorous activity,43330,0.20863098172,0.0222757261877423,0.164970558392026,0.252291405047975,8.34415496502022e-21
ACTN2,Alpha-actinin-2,Physical activities,X22040.Summed MET minutes per week for all activity,42671,0.0523524221992082,0.00444653295724098,0.0436372176030159,0.0610676267954006,6.89655776425379e-32
ACTN2,Alpha-actinin-2,Eye measures,X2217.Age started wearing glasses or contact lenses,42837,0.00120160817827847,0.00509607388334744,-0.00878669663308251,0.0111899129896395,0.813597423955929
ACTN2,Alpha-actinin-2,Working and living environment,X22501.Year ended full time education,29922,0.0141132700018397,0.0227640617710629,-0.0305042910694436,0.0587308310731229,0.535294055657298
ACTN2,Alpha-actinin-2,Lifestyle factors,X22506.Tobacco smoking,29883,-0.013373910921899,0.0784894177960073,-0.167213169802073,0.140465347958275,0.864708168861779
ACTN2,Alpha-actinin-2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,45970,0.0848075077956948,0.0440080755039587,-0.00144832019206419,0.171063335783454,0.0539812542754625
ACTN2,Alpha-actinin-2,Physical measures,X23098.Weight,47266,0.0677234021337956,0.00981294744041088,0.0484900251505903,0.086956779117001,5.27945227907063e-12
ACTN2,Alpha-actinin-2,Physical measures,X23099.Body fat percentage,47245,-0.144241068158291,0.00946032951492753,-0.162783314007549,-0.125698822309033,3.07805631210559e-52
ACTN2,Alpha-actinin-2,Physical measures,X23100.Whole body fat mass,47213,-0.0659810498544597,0.00903810291586256,-0.0836957315695503,-0.048266368139369,2.96266895324094e-13
ACTN2,Alpha-actinin-2,Physical measures,X23101.Whole body fat-free mass,47262,0.129692084571342,0.00834415777141802,0.113337535339363,0.146046633803321,3.32068384998404e-54
ACTN2,Alpha-actinin-2,Physical measures,X23102.Whole body water mass,47266,0.130505352379563,0.0083429725212557,0.114153126237902,0.146857578521224,7.08483750892529e-55
ACTN2,Alpha-actinin-2,Physical measures,X23104.Body mass index (BMI),47266,0.00803938035155173,0.0167239707635551,-0.0247396023450163,0.0408183630481197,0.630727100405864
ACTN2,Alpha-actinin-2,Physical measures,X23105.Basal metabolic rate,47264,0.12994888916017,0.00894847285589952,0.112409882362607,0.147487895957733,1.4178896262915e-47
ACTN2,Alpha-actinin-2,Physical measures,X23106.Impedance of whole body,47263,-0.125213141103333,0.00684056041622918,-0.138620639519142,-0.111805642687524,2.51622341117151e-74
ACTN2,Alpha-actinin-2,Physical measures,X23107.Impedance of leg (right),47263,-0.106294234240071,0.00564570386890729,-0.11735981382313,-0.0952286546570132,1.7118264510835e-78
ACTN2,Alpha-actinin-2,Physical measures,X23108.Impedance of leg (left),47262,-0.101445717270967,0.00559174372002502,-0.112405534962216,-0.0904858995797179,4.70256641176972e-73
ACTN2,Alpha-actinin-2,Physical measures,X23109.Impedance of arm (right),47257,-0.092170621316596,0.00688330857416486,-0.105661906121959,-0.0786793365112329,9.71454775114975e-41
ACTN2,Alpha-actinin-2,Physical measures,X23110.Impedance of arm (left),47261,-0.0969539335828736,0.00688256642194814,-0.110443763769892,-0.0834641033958552,6.97735044162205e-45
ACTN2,Alpha-actinin-2,Physical measures,X23111.Leg fat percentage (right),47262,-0.185153736742633,0.011666633933603,-0.208020339252495,-0.162287134232771,2.00283389860564e-56
ACTN2,Alpha-actinin-2,Physical measures,X23112.Leg fat mass (right),47261,-0.101469787106238,0.0121406205295318,-0.12526540334412,-0.0776741708683557,6.73680796660032e-17
ACTN2,Alpha-actinin-2,Physical measures,X23113.Leg fat-free mass (right),47261,0.142557992131304,0.00897301973808439,0.124970873444659,0.160145110817949,1.53089922688083e-56
ACTN2,Alpha-actinin-2,Physical measures,X23114.Leg predicted mass (right),47260,0.142482693315761,0.00901484566079051,0.124813595820612,0.160151790810911,5.57111134319734e-56
ACTN2,Alpha-actinin-2,Physical measures,X23115.Leg fat percentage (left),47259,-0.175559299272514,0.0120591474809291,-0.199195228335135,-0.151923370209893,8.38667576416901e-48
ACTN2,Alpha-actinin-2,Physical measures,X23116.Leg fat mass (left),47259,-0.0894754667054524,0.0126094562554919,-0.114190000966217,-0.0647609324446884,1.3217474032444e-12
ACTN2,Alpha-actinin-2,Physical measures,X23117.Leg fat-free mass (left),47257,0.138617045663626,0.00931305211585607,0.120363463516549,0.156870627810704,7.06593015189077e-50
ACTN2,Alpha-actinin-2,Physical measures,X23118.Leg predicted mass (left),47256,0.137884115343419,0.0093513962732954,0.11955537864776,0.156212852039078,5.51796629667348e-49
ACTN2,Alpha-actinin-2,Physical measures,X23119.Arm fat percentage (right),47256,-0.115991313738694,0.0104757277907684,-0.1365237402086,-0.0954588872687879,2.00955340915158e-28
ACTN2,Alpha-actinin-2,Physical measures,X23120.Arm fat mass (right),47254,-0.0359408187577378,0.0102566763273031,-0.056043904359252,-0.0158377331562237,0.000458942231074536
ACTN2,Alpha-actinin-2,Physical measures,X23121.Arm fat-free mass (right),47254,0.111035771572092,0.00836608362739798,0.0946382476623918,0.127433295481792,4.68922753952476e-40
ACTN2,Alpha-actinin-2,Physical measures,X23122.Arm predicted mass (right),47253,0.110467598651967,0.00836879209878983,0.0940647661383392,0.126870431165595,1.21703858490517e-39
ACTN2,Alpha-actinin-2,Physical measures,X23123.Arm fat percentage (left),47250,-0.130426328118277,0.0107243409181932,-0.151446036317936,-0.109406619918618,6.29366544083221e-34
ACTN2,Alpha-actinin-2,Physical measures,X23124.Arm fat mass (left),47250,-0.0363758573427355,0.010203141829279,-0.0563740153281223,-0.0163776993573488,0.000364355821261444
ACTN2,Alpha-actinin-2,Physical measures,X23125.Arm fat-free mass (left),47246,0.115754962734863,0.00849773088655309,0.0990994101972194,0.132410515272508,4.29834036338005e-42
ACTN2,Alpha-actinin-2,Physical measures,X23126.Arm predicted mass (left),47245,0.114482151652386,0.00854253903006132,0.0977387751534654,0.131225528151306,8.39140836317314e-41
ACTN2,Alpha-actinin-2,Physical measures,X23127.Trunk fat percentage,47243,-0.0873031952997282,0.00678684631335938,-0.100605414073913,-0.0740009765255438,9.6893157549329e-38
ACTN2,Alpha-actinin-2,Physical measures,X23128.Trunk fat mass,47239,-0.053426129121909,0.00741935197858639,-0.0679680589999383,-0.0388841992438797,6.16190881311259e-13
ACTN2,Alpha-actinin-2,Physical measures,X23129.Trunk fat-free mass,47234,0.111333473351101,0.00759726268401638,0.0964428384904292,0.126224108211773,2.07046337958541e-48
ACTN2,Alpha-actinin-2,Physical measures,X23130.Trunk predicted mass,47232,0.110695749810932,0.00758474942897842,0.095829640930134,0.125561858691729,4.9527410720332e-48
ACTN2,Alpha-actinin-2,NMR metabolomics,X23400.Total Cholesterol,37021,-0.0088320984755538,0.00578608254018997,-0.0201728202543261,0.00250862330321854,0.12692475482558
ACTN2,Alpha-actinin-2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37021,-0.0212125442634227,0.00560623793567042,-0.0322007706173367,-0.0102243179095087,0.000155174187613435
ACTN2,Alpha-actinin-2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37021,-0.0181689632097151,0.00563020535567405,-0.0292041657068362,-0.00713376071259396,0.00125378956497816
ACTN2,Alpha-actinin-2,NMR metabolomics,X23403.VLDL Cholesterol,37021,-0.0234112042657466,0.00553470833408517,-0.0342592326005535,-0.0125631759309397,2.35387770460827e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37021,-0.0225828782347846,0.00559844760593675,-0.0335558355424206,-0.0116099209271486,5.5197770209108e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23405.LDL Cholesterol,37021,-0.022785664238864,0.00555491444912404,-0.0336732965591472,-0.0118980319185809,4.12249640073354e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23406.HDL Cholesterol,37021,0.0392536552948687,0.00631844261376117,0.0268695077718968,0.0516378028178406,5.37017661139041e-10
ACTN2,Alpha-actinin-2,NMR metabolomics,X23407.Total Triglycerides,37021,-0.0184114694116301,0.005674106451603,-0.029532718056772,-0.00729022076648823,0.00117817248088059
ACTN2,Alpha-actinin-2,NMR metabolomics,X23408.Triglycerides in VLDL,37021,-0.0211413196371664,0.00576394905917311,-0.0324386597931457,-0.00984397948118707,0.00024555975158107
ACTN2,Alpha-actinin-2,NMR metabolomics,X23409.Triglycerides in LDL,37021,-0.00563190010441906,0.00543412176304513,-0.0162827787599875,0.00501897855114939,0.300036644877659
ACTN2,Alpha-actinin-2,NMR metabolomics,X23410.Triglycerides in HDL,37021,-0.00687015528185657,0.0053569577926963,-0.0173697925555413,0.00362948199182818,0.199699256269543
ACTN2,Alpha-actinin-2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37021,0.00375536158440767,0.00572657112989988,-0.0074687178301961,0.0149794409990114,0.511978187197006
ACTN2,Alpha-actinin-2,NMR metabolomics,X23412.Phospholipids in VLDL,37021,-0.0232723852319098,0.00559056266224155,-0.0342298880499032,-0.0123148824139164,3.1637170276751e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23413.Phospholipids in LDL,37021,-0.024016445053366,0.00555754246042284,-0.0349092282757948,-0.0131236618309372,1.5617013280225e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23414.Phospholipids in HDL,37021,0.0351579494092944,0.00592448661134886,0.0235459556510506,0.0467699431675382,3.0243946720846e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23415.Total Esterified Cholesterol,37021,-0.00774750848803223,0.00580818370741023,-0.0191315485545563,0.00363653157849183,0.182261280000601
ACTN2,Alpha-actinin-2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37021,-0.0225877559707397,0.00553662810448689,-0.033439547055534,-0.0117359648859454,4.53605583317771e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37021,-0.0234317496986712,0.00553358280888029,-0.0342775720040766,-0.0125859273932658,2.30654987746866e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37021,0.0380514300476947,0.00630579437630353,0.0256920730701398,0.0504107870252496,1.63881298162031e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23419.Total Free Cholesterol,37021,-0.0112201470819426,0.00572524329111723,-0.0224416239325323,1.32976864720621e-06,0.0500440166622237
ACTN2,Alpha-actinin-2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37021,-0.0239779991345393,0.00556281159824992,-0.0348811098671091,-0.0130748884019695,1.64136689049122e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23421.Free Cholesterol in LDL,37021,-0.020242283366324,0.00562183126362818,-0.0312610726430352,-0.00922349408961275,0.000318582222775215
ACTN2,Alpha-actinin-2,NMR metabolomics,X23422.Free Cholesterol in HDL,37021,0.0408929817252861,0.00626653858757845,0.0286105660936323,0.0531753973569398,7.02061974974068e-11
ACTN2,Alpha-actinin-2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37021,-0.00920729619069518,0.00558062624956995,-0.0201453236398523,0.00173073125846192,0.0989938178983716
ACTN2,Alpha-actinin-2,NMR metabolomics,X23424.Total Lipids in VLDL,37021,-0.0232673578277228,0.00564137389571433,-0.0343244506633229,-0.0122102649921228,3.73964405936766e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23425.Total Lipids in LDL,37021,-0.0227253588857715,0.00554909351566838,-0.0336015821764815,-0.0118491355950615,4.24092075283802e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23426.Total Lipids in HDL,37021,0.0362044734781658,0.00605906908956183,0.0243286980626246,0.048080248893707,2.35668594549407e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37021,0.00668894191485308,0.00573641542538897,-0.0045544323189093,0.0179323161486155,0.243615733559425
ACTN2,Alpha-actinin-2,NMR metabolomics,X23428.Concentration of VLDL Particles,37021,-0.0218479257075441,0.0055228402395989,-0.0326726925771579,-0.0110231588379302,7.66397946017581e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23429.Concentration of LDL Particles,37021,-0.0230128375291154,0.00555220341710984,-0.0338951562266506,-0.0121305188315801,3.42222176540429e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23430.Concentration of HDL Particles,37021,0.0108721292790093,0.00572888593133585,-0.00035648714640898,0.0221007457044275,0.0577477555165471
ACTN2,Alpha-actinin-2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37021,-0.0285449007509746,0.00604107121113263,-0.0403854003247945,-0.0167044011771546,2.32337041164269e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37021,0.0114288109945828,0.00553467878164714,0.000580840582554422,0.0222767814066112,0.0389476808700801
ACTN2,Alpha-actinin-2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37021,0.0646624642106289,0.00639682504258934,0.0521246871271538,0.077200241294104,6.19252427245808e-24
ACTN2,Alpha-actinin-2,NMR metabolomics,X23434.Phosphoglycerides,37009,0.00958655530367855,0.0056541257680077,-0.00149553120161654,0.0206686418089737,0.090004785769918
ACTN2,Alpha-actinin-2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37009,-0.0275635445903671,0.00606567728743566,-0.039452272073741,-0.0156748171069932,5.56401917497189e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23436.Total Cholines,37009,0.00960346373492406,0.00575387653090103,-0.00167413426564195,0.0208810617354901,0.095132788970751
ACTN2,Alpha-actinin-2,NMR metabolomics,X23437.Phosphatidylcholines,37009,0.00846806106863151,0.005735853872668,-0.00277421252179778,0.0197103346590608,0.139877029349773
ACTN2,Alpha-actinin-2,NMR metabolomics,X23438.Sphingomyelins,37008,0.00684301479885624,0.00594782985684252,-0.00481473172055509,0.0185007613182676,0.249956388732629
ACTN2,Alpha-actinin-2,NMR metabolomics,X23439.Apolipoprotein B,37021,-0.021920174688024,0.00557332179457058,-0.0328438854053823,-0.0109964639706657,8.43037054785473e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23440.Apolipoprotein A1,37021,0.025470013882699,0.00589348682887924,0.0139187796980957,0.0370212480673023,1.55952704458264e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37021,-0.0320106662925756,0.00554423757458363,-0.0428773719387595,-0.0211439606463917,7.93083806483109e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23442.Total Fatty Acids,37009,-0.00293748324579979,0.00543037789204241,-0.0135810239142029,0.00770605742260333,0.588561322958507
ACTN2,Alpha-actinin-2,NMR metabolomics,X23443.Degree of Unsaturation,37009,0.00228389989513375,0.00598965828518361,-0.00945583034382613,0.0140236301340936,0.702981464434546
ACTN2,Alpha-actinin-2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37009,-0.00250344862547896,0.00552238554540766,-0.013327324294478,0.00832042704352004,0.650320493385005
ACTN2,Alpha-actinin-2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37009,-0.00423138016295399,0.00551536699906553,-0.0150414994811224,0.00657873915521445,0.442977400877234
ACTN2,Alpha-actinin-2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37009,-0.00386106617523131,0.00552133287805272,-0.0146828786162146,0.00696074626575203,0.484377152369936
ACTN2,Alpha-actinin-2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37009,-0.00301798863458673,0.00551716043576631,-0.0138316230886887,0.00779564581951524,0.584375329280543
ACTN2,Alpha-actinin-2,NMR metabolomics,X23448.Saturated Fatty Acids,37009,-0.00129082634127509,0.00545399013857213,-0.0119806470128765,0.00939899433032628,0.812912159045061
ACTN2,Alpha-actinin-2,NMR metabolomics,X23449.Linoleic Acid,37009,-0.00720855148859058,0.00555412731155087,-0.0180946410192303,0.00367753804204914,0.194353769640112
ACTN2,Alpha-actinin-2,NMR metabolomics,X23450.Docosahexaenoic Acid,37009,0.00144897387028319,0.0057656804786733,-0.00985175986791647,0.0127497076084828,0.801578276376103
ACTN2,Alpha-actinin-2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37009,-0.00134278570809618,0.0055804655876092,-0.0122804982598102,0.00959492684361784,0.809851443702261
ACTN2,Alpha-actinin-2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37009,-0.00362423356873369,0.00567639967776683,-0.0147499769371567,0.00750150979968929,0.523176297988737
ACTN2,Alpha-actinin-2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37009,-0.00267681292211564,0.00589198361367514,-0.0142251008049189,0.00887147496068763,0.649610061776611
ACTN2,Alpha-actinin-2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37009,-0.00268922234009149,0.00602614363298875,-0.0145004638607494,0.00912201918056646,0.655417336482316
ACTN2,Alpha-actinin-2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37009,0.0040881583960243,0.00542219517092418,-0.00653934413898709,0.0147156609310357,0.450882298148606
ACTN2,Alpha-actinin-2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37009,-0.00978376478923951,0.0058042497168104,-0.0211600942341879,0.00159256465570887,0.091892562723509
ACTN2,Alpha-actinin-2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37009,0.00387307656961928,0.00582020088004304,-0.00753451715526507,0.0152806702945036,0.505771760963659
ACTN2,Alpha-actinin-2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37009,0.00132697036487846,0.00601820555955516,-0.0104687125318497,0.0131226532616066,0.825490883925383
ACTN2,Alpha-actinin-2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37007,0.00114143507458485,0.00553782411514214,-0.00971270019109374,0.0119955703402634,0.83670336282826
ACTN2,Alpha-actinin-2,NMR metabolomics,X23460.Alanine,37017,-0.0407242599447305,0.00538441774220512,-0.0512777187194526,-0.0301708011700085,4.18830167311938e-14
ACTN2,Alpha-actinin-2,NMR metabolomics,X23461.Glutamine,36984,0.0105566083670201,0.0053533929986696,6.39580896276831e-05,0.0210492586444125,0.0486365994110588
ACTN2,Alpha-actinin-2,NMR metabolomics,X23462.Glycine,37005,-0.00833356657900591,0.0055886669218116,-0.0192873537457566,0.00262022058774483,0.135944896798349
ACTN2,Alpha-actinin-2,NMR metabolomics,X23463.Histidine,37007,0.00279009190569193,0.00531074749655419,-0.00761897318755429,0.0131991569989382,0.599336893626761
ACTN2,Alpha-actinin-2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37010,0.00518471575024771,0.00567340784129289,-0.00593516361868634,0.0163045951191818,0.360805755807828
ACTN2,Alpha-actinin-2,NMR metabolomics,X23465.Isoleucine,37019,0.027236555317286,0.00552309044472967,0.0164112980456158,0.0380618125889561,8.26397625489717e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23466.Leucine,37020,0.0128980964288719,0.00569658232789515,0.00173279506619738,0.0240633977915464,0.0235791552998837
ACTN2,Alpha-actinin-2,NMR metabolomics,X23467.Valine,37010,-0.00846712778123768,0.00565382511620425,-0.019548625008998,0.00261436944652266,0.134263080671231
ACTN2,Alpha-actinin-2,NMR metabolomics,X23468.Phenylalanine,37017,0.0346907692697465,0.0053356946478245,0.0242328077600105,0.0451487307794825,8.23171617032477e-11
ACTN2,Alpha-actinin-2,NMR metabolomics,X23469.Tyrosine,37007,0.00253376307863714,0.00548844334151179,-0.00822358587072597,0.0132911120280003,0.644336937518696
ACTN2,Alpha-actinin-2,NMR metabolomics,X23470.Glucose,37001,0.0131341805427647,0.00548957085387662,0.00237462166916653,0.0238937394163629,0.0167448099524548
ACTN2,Alpha-actinin-2,NMR metabolomics,X23471.Lactate,37000,-0.0375772552909073,0.00538436555166665,-0.048130611772174,-0.0270238988096407,3.11645445846603e-12
ACTN2,Alpha-actinin-2,NMR metabolomics,X23472.Pyruvate,36981,-0.0132866121552448,0.0053191735356517,-0.0237121922851221,-0.00286103202536745,0.0125062914512476
ACTN2,Alpha-actinin-2,NMR metabolomics,X23473.Citrate,37020,0.04831471905751,0.0054302192952009,0.0376714892389163,0.0589579488761038,6.45718358897052e-19
ACTN2,Alpha-actinin-2,NMR metabolomics,X23474.3-Hydroxybutyrate,36813,0.039349608989218,0.00532805764126321,0.0289066160123421,0.0497926019660939,1.61340416104749e-13
ACTN2,Alpha-actinin-2,NMR metabolomics,X23475.Acetate,37011,0.039174193058018,0.00531013283738958,0.0287663326967345,0.0495820534193016,1.71272407398456e-13
ACTN2,Alpha-actinin-2,NMR metabolomics,X23476.Acetoacetate,37021,0.0620459037610141,0.00525936856806282,0.051737541367611,0.0723542661544172,5.84428202863802e-32
ACTN2,Alpha-actinin-2,NMR metabolomics,X23477.Acetone,37021,0.0685871830915459,0.0052756673497925,0.0582468750859526,0.0789274910971392,2.0904292117206e-38
ACTN2,Alpha-actinin-2,NMR metabolomics,X23478.Creatinine,36688,0.071207287386322,0.00668063792244983,0.0581132370583203,0.0843013377143237,2.04693156645589e-26
ACTN2,Alpha-actinin-2,NMR metabolomics,X23479.Albumin,37020,0.011001187195295,0.00545031861469965,0.000318562710483682,0.0216838116801063,0.04356482287619
ACTN2,Alpha-actinin-2,NMR metabolomics,X23480.Glycoprotein Acetyls,37021,-0.0150403423527891,0.0057168597095678,-0.0262453873835419,-0.00383529732203616,0.00852646200846399
ACTN2,Alpha-actinin-2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37021,-0.00980050009672959,0.0057392299050015,-0.0210493907105325,0.00144839051707336,0.087727990066728
ACTN2,Alpha-actinin-2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37021,-0.00839105696255086,0.00577276931329904,-0.019705684816617,0.00292357089151527,0.146092638773721
ACTN2,Alpha-actinin-2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37021,-0.01234195829343,0.00577223808086156,-0.0236555449319186,-0.0010283716549413,0.0325222657858326
ACTN2,Alpha-actinin-2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37021,-0.0146440643809559,0.00572802104941655,-0.0258709856378124,-0.00341714312409949,0.0105822212575231
ACTN2,Alpha-actinin-2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37021,-0.0165942515377357,0.00574035480585461,-0.0278453469572107,-0.00534315611826066,0.00384883810767493
ACTN2,Alpha-actinin-2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37021,-0.00997193258335207,0.00568671312957096,-0.0211178903173111,0.001174025150607,0.0795310186207555
ACTN2,Alpha-actinin-2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37021,-0.00506961020183251,0.00576502351018454,-0.0163690562817942,0.00622983587812919,0.379214728761979
ACTN2,Alpha-actinin-2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37021,-0.0255326404546216,0.00582390781873424,-0.0369474997793407,-0.0141177811299025,1.17365405607632e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37021,-0.0251090964212464,0.00583189592697797,-0.0365396124381232,-0.0136785804043695,1.67831980787098e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37021,-0.0243599098757561,0.0057975400639782,-0.0357230884011534,-0.0129967313503588,2.66586657087066e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37021,-0.0280721987354757,0.00571233884401908,-0.0392683828697531,-0.0168760146011983,9.01687940638908e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37021,-0.0308130803603763,0.00566027567234325,-0.041907220678169,-0.0197189400425835,5.31079786321151e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37021,-0.0237473743108872,0.00575226093918522,-0.0350218057516902,-0.0124729428700841,3.6762089508461e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37021,-0.0229540336318344,0.00588873154767608,-0.0344959474652795,-0.0114121197983892,9.74879088497654e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37021,-0.0271571669049652,0.00576245942216704,-0.0384515873724126,-0.0158627464375178,2.46870193731699e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37021,-0.0282036405219273,0.00576646914733049,-0.039505920050695,-0.0169013609931595,1.01525127749091e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37021,-0.0291655861940154,0.00579826912244101,-0.0405301936739998,-0.017800978714031,4.9681196627439e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37021,-0.0293050664710211,0.00566845242274328,-0.0404152332195979,-0.0181948997224443,2.3771194261068e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37021,-0.0286081050697084,0.00557621094298282,-0.0395374785179547,-0.0176787316214621,2.93265004903193e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37021,-0.0295411660027893,0.00577129703579417,-0.0408529081929458,-0.0182294238126327,3.12093642259601e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37021,-0.0255968751752516,0.00580180366583665,-0.0369684103602914,-0.0142253399902118,1.03290153220421e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37021,-0.0262853959413413,0.0055229193434727,-0.0371103178545478,-0.0154604740281348,1.96302703336526e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37021,-0.0269892358740269,0.00554303415126868,-0.0378535828105135,-0.0161248889375403,1.13446353747739e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37021,-0.0257442292165412,0.00552517250712037,-0.0365735673304972,-0.0149148911025853,3.20173128963771e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37021,-0.0225550359366955,0.00558323487555801,-0.0334981762927892,-0.0116118955806019,5.38053393755081e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37021,-0.0192755126963745,0.00564628695891225,-0.0303422351358425,-0.00820879025690652,0.000642475948861321
ACTN2,Alpha-actinin-2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37021,-0.0250882918615552,0.00552470648553023,-0.0359167165731945,-0.014259867149916,5.64560076491999e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37021,-0.0263100281509792,0.00567785100986021,-0.0374386161303052,-0.0151814401716532,3.62458101973778e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37021,-0.0244705736338818,0.00554134098115794,-0.0353316019569513,-0.0136095453108122,1.0134494968988e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37021,-0.0249970501374484,0.00552975819261294,-0.0358353761949698,-0.0141587240799271,6.22437391206247e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37021,-0.025796135998928,0.00549515097001315,-0.0365666319001538,-0.0150256400977023,2.7015999909016e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37021,-0.0270725541243583,0.00550529517225218,-0.0378629326619726,-0.0162821755867441,8.86927074237069e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37021,-0.0274838650012013,0.00551294661246736,-0.0382892403616373,-0.0166784896407653,6.2643051814579e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37021,-0.0260008697521465,0.00551118309506994,-0.0368027886184836,-0.0151989508858094,2.40815273449738e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37021,-0.0185357383367228,0.00559484015691655,-0.0295016250442792,-0.00756985162916637,0.000925479638685938
ACTN2,Alpha-actinin-2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37021,-0.00989048503354126,0.00555350893400772,-0.0207753625441964,0.000994392477113873,0.074944757201549
ACTN2,Alpha-actinin-2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37021,-0.00682208732242252,0.00553415461635475,-0.0176690303704778,0.00402485572563279,0.217700631656287
ACTN2,Alpha-actinin-2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37021,-0.00576516016063421,0.00549668257562508,-0.0165386580088594,0.00500833768759094,0.294269381760027
ACTN2,Alpha-actinin-2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37021,-0.00679091821023616,0.00574093966288801,-0.0180431599494967,0.00446132352902433,0.236872864029967
ACTN2,Alpha-actinin-2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37021,-0.00586322626843367,0.0058165452081854,-0.0172636548764771,0.00553720233960972,0.313460721553099
ACTN2,Alpha-actinin-2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37021,-0.00868761803803531,0.00557430416030101,-0.0196132541922253,0.00223801811615467,0.119136050347338
ACTN2,Alpha-actinin-2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37021,-0.00652557138855029,0.00544210683928921,-0.0171921007935571,0.00414095801645656,0.230514861866709
ACTN2,Alpha-actinin-2,NMR metabolomics,X23523.Concentration of IDL Particles,37021,-0.0138015878613197,0.00570739350333167,-0.0249880791278498,-0.0026150965947896,0.0156112209631866
ACTN2,Alpha-actinin-2,NMR metabolomics,X23524.Total Lipids in IDL,37021,-0.00873506755723458,0.0058453316630727,-0.0201919176168571,0.00272178250238791,0.135103838568119
ACTN2,Alpha-actinin-2,NMR metabolomics,X23525.Phospholipids in IDL,37021,-0.00781737582143404,0.00583937021765737,-0.0192625414480425,0.0036277898051744,0.180679716941866
ACTN2,Alpha-actinin-2,NMR metabolomics,X23526.Cholesterol in IDL,37021,-0.00918995325769081,0.00588007218996927,-0.0207148947500306,0.00233498823464896,0.118100623817782
ACTN2,Alpha-actinin-2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37021,-0.00958482488341532,0.00587420675549586,-0.0210982701241872,0.00192862035735656,0.102770869283634
ACTN2,Alpha-actinin-2,NMR metabolomics,X23528.Free Cholesterol in IDL,37021,-0.0077451187426587,0.00586950999800943,-0.0192493583387572,0.00375912085343978,0.187007871164652
ACTN2,Alpha-actinin-2,NMR metabolomics,X23529.Triglycerides in IDL,37021,-0.0009649599293372,0.00537821040944254,-0.0115062523318446,0.00957633247317017,0.857610483531858
ACTN2,Alpha-actinin-2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37021,-0.0195045503912353,0.00556522463943697,-0.0304123906845317,-0.00859671009793881,0.000458608622593414
ACTN2,Alpha-actinin-2,NMR metabolomics,X23531.Total Lipids in Large LDL,37021,-0.0197017493288498,0.0055967229219222,-0.0306713262558173,-0.00873217240188233,0.000432630907167489
ACTN2,Alpha-actinin-2,NMR metabolomics,X23532.Phospholipids in Large LDL,37021,-0.0223217050667382,0.00561034113811746,-0.0333179736974484,-0.011325436436028,6.96727663287042e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23533.Cholesterol in Large LDL,37021,-0.0193636189165445,0.0056060876842979,-0.0303515507777683,-0.00837568705532059,0.000554006273497865
ACTN2,Alpha-actinin-2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37021,-0.020021014370457,0.00557428215233253,-0.0309466073890287,-0.00909542135188522,0.000329755684787383
ACTN2,Alpha-actinin-2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37021,-0.0170241773936906,0.00569838233088906,-0.0281930067622332,-0.00585534802514806,0.0028174576684672
ACTN2,Alpha-actinin-2,NMR metabolomics,X23536.Triglycerides in Large LDL,37021,-0.00342435808932269,0.00540476321913308,-0.0140176939988235,0.00716897782017815,0.526364975083286
ACTN2,Alpha-actinin-2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37021,-0.0283876614387896,0.00551669673862364,-0.0392003870464919,-0.0175749358310873,2.70258209791713e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37021,-0.0284233311873873,0.00549906324239813,-0.0392014951424876,-0.0176451672322869,2.39105088944303e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37021,-0.0280484039593487,0.00549056261973388,-0.038809906694027,-0.0172869012246703,3.29312997167227e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37021,-0.0290314073103052,0.00549934606232368,-0.0398101255924596,-0.0182526890281507,1.3190903563845e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37021,-0.0297816626446372,0.0055057634760869,-0.0405729590577675,-0.0189903662315069,6.44211890361982e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37021,-0.025391296368414,0.00550445626219796,-0.036180030642322,-0.014602562094506,4.00907357224455e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37021,-0.00856345384156935,0.0054770943868683,-0.0192985588398312,0.00217165115669251,0.117958359281328
ACTN2,Alpha-actinin-2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37021,-0.0238930793066796,0.00554648678892739,-0.0347641934129773,-0.0130219652003819,1.66092600793632e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23545.Total Lipids in Small LDL,37021,-0.0237877157249855,0.00554002222340381,-0.0346461592828569,-0.012929272167114,1.76903400101738e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23546.Phospholipids in Small LDL,37021,-0.0191316296122665,0.00555335959217478,-0.0300162144129291,-0.00824704481160394,0.000572723570867158
ACTN2,Alpha-actinin-2,NMR metabolomics,X23547.Cholesterol in Small LDL,37021,-0.0257144730556731,0.0055294833311814,-0.0365522603847886,-0.0148766857265576,3.34466870905977e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37021,-0.0255600544775251,0.00553306228398817,-0.036404856554142,-0.0147152524009083,3.88288530688769e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37021,-0.023557372160734,0.00551359059561473,-0.0343640097281388,-0.0127507345933291,1.94564111363936e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23550.Triglycerides in Small LDL,37021,-0.0100398380245934,0.00554068129066611,-0.020899573354299,0.000819897305112166,0.0700055322381934
ACTN2,Alpha-actinin-2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37021,0.0542192805936991,0.00646774377358134,0.0415425027974797,0.0668960583899186,5.67874753845712e-17
ACTN2,Alpha-actinin-2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37021,0.0604030001652429,0.00647350765025212,0.0477149251707487,0.073091075159737,1.21670328309635e-20
ACTN2,Alpha-actinin-2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37021,0.0623253034246621,0.00639184651010673,0.0497972842648529,0.0748533225844713,2.18012430531545e-22
ACTN2,Alpha-actinin-2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37021,0.0564856863501635,0.00658143054655132,0.0435860824789229,0.0693852902214041,1.03081907546099e-17
ACTN2,Alpha-actinin-2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37021,0.0582505855828511,0.00665996148601313,0.0451970610702653,0.0713041100954368,2.46803626952375e-18
ACTN2,Alpha-actinin-2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37021,0.0465885417517838,0.00618821353298147,0.0344596432271401,0.0587174402764275,5.46241903587187e-14
ACTN2,Alpha-actinin-2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37021,0.00933479496531448,0.005270782946308,-0.00099593960944919,0.0196655295400782,0.0765763215215634
ACTN2,Alpha-actinin-2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37021,0.0585038426281459,0.00660708150494068,0.0455539628784622,0.0714537223778297,9.45227835228952e-19
ACTN2,Alpha-actinin-2,NMR metabolomics,X23559.Total Lipids in Large HDL,37021,0.0595509655277785,0.00650449936910832,0.0468021467643262,0.0722997842912308,6.20787351385857e-20
ACTN2,Alpha-actinin-2,NMR metabolomics,X23560.Phospholipids in Large HDL,37021,0.0581356130675383,0.00636146556383532,0.0456671405624211,0.0706040855726555,7.2339942310805e-20
ACTN2,Alpha-actinin-2,NMR metabolomics,X23561.Cholesterol in Large HDL,37021,0.0599311146488618,0.00666435243593545,0.0468689838744283,0.0729932454232953,2.73612115564603e-19
ACTN2,Alpha-actinin-2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37021,0.0590608968111987,0.00667772706430783,0.0459725517651554,0.072149241857242,1.03564748434465e-18
ACTN2,Alpha-actinin-2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37021,0.060896396140836,0.00657132665406957,0.0480165958988596,0.0737761963828124,2.20852698487339e-20
ACTN2,Alpha-actinin-2,NMR metabolomics,X23564.Triglycerides in Large HDL,37021,0.0139053471895779,0.0053059136364713,0.00350575646209416,0.0243049379170617,0.00878435130725218
ACTN2,Alpha-actinin-2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37021,0.0253281789493286,0.00582124552922845,0.0139185377120408,0.0367378201866164,1.36545626478474e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37021,0.0240301856195657,0.00572626593548536,0.0128067043860144,0.035253666853117,2.72869275127808e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37021,0.0229537603115172,0.00562986899196775,0.0119192170872605,0.033988303535774,4.58612710842919e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37021,0.0272803948730644,0.00591126054532881,0.0156943242042199,0.0388664655419088,3.96832083661572e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37021,0.0266109570073533,0.00589921570026723,0.0150484942348296,0.0381734197798771,6.51021295886931e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37021,0.0290697048117221,0.00592915653076943,0.017448558011414,0.0406908516120302,9.55880563530659e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37021,-0.00775140604496189,0.00537354048925092,-0.0182835454038937,0.00278073331396991,0.149181292395198
ACTN2,Alpha-actinin-2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37021,-0.0214089585364927,0.00533307631080544,-0.0318617881056713,-0.010956128967314,5.99344071578997e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23573.Total Lipids in Small HDL,37021,-0.015014429329265,0.00535674752972988,-0.0255136544875356,-0.00451520417099446,0.0050719389986095
ACTN2,Alpha-actinin-2,NMR metabolomics,X23574.Phospholipids in Small HDL,37021,-0.00927692252527876,0.00536281707945962,-0.0197880440010196,0.0012341989504621,0.083678743591477
ACTN2,Alpha-actinin-2,NMR metabolomics,X23575.Cholesterol in Small HDL,37021,-0.0184325972226656,0.00532702580988343,-0.0288735678100372,-0.0079916266352941,0.000541476882973231
ACTN2,Alpha-actinin-2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37021,-0.0208455231111891,0.00530531873011256,-0.0312439478222097,-0.0104470984001685,8.56736001457395e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37021,-0.00830024754897456,0.00541889916315549,-0.0189212899087593,0.00232079481081021,0.12561506424972
ACTN2,Alpha-actinin-2,NMR metabolomics,X23578.Triglycerides in Small HDL,37021,-0.0250776952613088,0.00577668967462761,-0.0364000070235789,-0.0137553834990387,1.42773104625326e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.00913074676498597,0.00543473558963044,-0.0197828285206616,0.00152133499068969,0.0929682457499795
ACTN2,Alpha-actinin-2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.0129337726696343,0.00541650081184143,-0.0235501142608435,-0.00231743107842511,0.0169621411301248
ACTN2,Alpha-actinin-2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.0169754321369579,0.00537034290881747,-0.0275013042382401,-0.00644956003567564,0.00157625256761373
ACTN2,Alpha-actinin-2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.000240139452941603,0.00549255040756775,-0.0110055382517744,0.0105252593458912,0.965127546098962
ACTN2,Alpha-actinin-2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,0.0165065961264426,0.00530897948700077,0.00610099633192108,0.0269121959209641,0.00188025023901273
ACTN2,Alpha-actinin-2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,36855,-0.00752973889606915,0.005261312948537,-0.0178419122752017,0.00278243448306338,0.152410685150683
ACTN2,Alpha-actinin-2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,36855,4.82631651855344e-05,0.00590720161149009,-0.0115298519933351,0.0116263783237061,0.99348130170228
ACTN2,Alpha-actinin-2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,36855,-0.00168286859039542,0.00588604603665342,-0.0132195188222361,0.00985378164144529,0.774953021169506
ACTN2,Alpha-actinin-2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,36855,0.00809804073110842,0.00563196374132076,-0.00294060820188027,0.0191366896640971,0.150494568045753
ACTN2,Alpha-actinin-2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,36855,0.00388016522327062,0.00572528076038081,-0.00734138506707577,0.015101715513617,0.497958213449274
ACTN2,Alpha-actinin-2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37017,-0.0218817266707972,0.00571090199805993,-0.0330750945869946,-0.0106883587545997,0.000127919490136596
ACTN2,Alpha-actinin-2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37017,-0.00608979897484918,0.00549326686429671,-0.0168566020288707,0.00467700407917237,0.267625923158327
ACTN2,Alpha-actinin-2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37017,-0.000216952304320786,0.00573746923740141,-0.0114623920096276,0.011028487400986,0.969837161189021
ACTN2,Alpha-actinin-2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37017,-0.0155771210132493,0.00535143282441359,-0.0260659293490999,-0.00508831267739866,0.00361072664846509
ACTN2,Alpha-actinin-2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37017,0.0162531380754689,0.00526862605740753,0.00592663100295019,0.0265796451479877,0.00204048909287047
ACTN2,Alpha-actinin-2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37021,-0.00122860988129721,0.00579124529300244,-0.012579450655582,0.0101222308929876,0.831993676524185
ACTN2,Alpha-actinin-2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37021,0.00632117433993467,0.00603101540856901,-0.00549961586086059,0.0181419645407299,0.294606658594383
ACTN2,Alpha-actinin-2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37021,0.00740107407203064,0.00604798545116131,-0.00445297741224552,0.0192551255563068,0.221077701030136
ACTN2,Alpha-actinin-2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37021,0.00276259703668889,0.00591897150935857,-0.00883858712165391,0.0143637811950317,0.64069650180107
ACTN2,Alpha-actinin-2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37021,-0.0046561971832838,0.00599488031021128,-0.0164061625912979,0.00709376822473031,0.43735233970147
ACTN2,Alpha-actinin-2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37021,-0.00157018965502323,0.00575594160734095,-0.0128518352054115,0.00971145589536502,0.785015408502537
ACTN2,Alpha-actinin-2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37021,-0.00909238079384027,0.00555083113816891,-0.0199720098246513,0.00178724823697079,0.10144111227084
ACTN2,Alpha-actinin-2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37021,-0.0130194304990618,0.00539112179105726,-0.023586029209534,-0.00245283178858953,0.015749782899215
ACTN2,Alpha-actinin-2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37021,-0.00209145837274669,0.00579685843531427,-0.0134533009059627,0.00927038416046928,0.71826096324591
ACTN2,Alpha-actinin-2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37021,0.00699280658307143,0.0056134555227239,-0.00400956624146742,0.0179951794076103,0.212888548897665
ACTN2,Alpha-actinin-2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37021,0.00656155384669724,0.00561390197430842,-0.00444169402294726,0.0175648017163417,0.24250357963294
ACTN2,Alpha-actinin-2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37021,0.00117696465142972,0.00590124362152071,-0.0103894728467509,0.0127434021496103,0.841918921049089
ACTN2,Alpha-actinin-2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37021,0.00335179253918439,0.00596858502122149,-0.00834663410240972,0.0150502191807785,0.574416960240934
ACTN2,Alpha-actinin-2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37021,-0.0117349561943119,0.00537106257398793,-0.0222622388393283,-0.00120767354929558,0.028917557533092
ACTN2,Alpha-actinin-2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37021,-0.00265861433036902,0.0058408814806929,-0.0141067420325271,0.00878951337178906,0.648991948811985
ACTN2,Alpha-actinin-2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37021,0.00666110714947361,0.00543439490868914,-0.0039903068715571,0.0173125211705043,0.22032179462641
ACTN2,Alpha-actinin-2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37021,-0.00605437171327089,0.00567540548722831,-0.0171781664682384,0.00506942304169659,0.286093732680686
ACTN2,Alpha-actinin-2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37021,-0.00895280068758019,0.00562715900126874,-0.0199820323300669,0.00207643095490655,0.111633964578616
ACTN2,Alpha-actinin-2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37021,0.00240400461574526,0.00553760952104263,-0.0084497100454983,0.0132577192769888,0.66420611520151
ACTN2,Alpha-actinin-2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37021,0.00569184403582031,0.00572301565908463,-0.00552526665598557,0.0169089547276262,0.31997186111221
ACTN2,Alpha-actinin-2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37021,-0.0139013036173218,0.00541997595243187,-0.0245244564840882,-0.00327815075055532,0.0103336959389015
ACTN2,Alpha-actinin-2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37021,-0.0072435897035801,0.00569109699319463,-0.0183981398102416,0.00391096040308138,0.203113908895091
ACTN2,Alpha-actinin-2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37021,-0.0154097815572011,0.00535407535798033,-0.0259037692588426,-0.00491579385555964,0.00400670729948068
ACTN2,Alpha-actinin-2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37021,0.0106310024251317,0.00599514838059339,-0.00111948840083131,0.0223814932510948,0.0762074957646284
ACTN2,Alpha-actinin-2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37021,0.0155558822966069,0.00554936355295576,0.0046791297328136,0.0264326348604002,0.00506749594104008
ACTN2,Alpha-actinin-2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37021,0.00886315716807235,0.00536466993853386,-0.00165159591145402,0.0193779102475987,0.0985309566395032
ACTN2,Alpha-actinin-2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37021,-0.0230347502958934,0.00557063082838784,-0.0339531867195336,-0.0121163138722533,3.57103307079144e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37021,-0.0266980905817064,0.00554485760579449,-0.0375660114890636,-0.0158301696743492,1.4889110805223e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37021,0.00999730147906555,0.00581929931543576,-0.00140852517918854,0.0214031281373196,0.0858281219635435
ACTN2,Alpha-actinin-2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37021,0.0215554975196505,0.00541911945624195,0.0109340233854162,0.0321769716538847,6.99649117776964e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37021,0.0261066027496786,0.00548223300840948,0.015361426053196,0.0368517794461612,1.93690476733059e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37021,-0.0283697147523022,0.00539001666849103,-0.0389341474225446,-0.0178052820820598,1.43652407893114e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37021,-0.0226224422322142,0.00549282462565031,-0.0333883784984888,-0.0118565059659396,3.83602877264047e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37021,-0.00684201505436718,0.00554258901769836,-0.017705489529056,0.00402145942032161,0.217059589378768
ACTN2,Alpha-actinin-2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37021,0.00824724770610887,0.00556677907396057,-0.00266363927885385,0.0191581346910716,0.138494239732802
ACTN2,Alpha-actinin-2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37018,0.0594079552276619,0.00605033613752395,0.0475492963981149,0.0712666140572088,1.11642529263175e-22
ACTN2,Alpha-actinin-2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37018,-0.042900223189893,0.00556555226983994,-0.0538087056387793,-0.0319917407410067,1.36767258332406e-14
ACTN2,Alpha-actinin-2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37018,-0.0202309850517313,0.00532439835041899,-0.0306668058185525,-0.0097951642849101,0.000145538325178061
ACTN2,Alpha-actinin-2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37018,-0.0585943542604484,0.00638848679220344,-0.0711157883731671,-0.0460729201477297,5.3318323654084e-20
ACTN2,Alpha-actinin-2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37018,-0.0368968701516213,0.00595612139852004,-0.0485708680927206,-0.025222872210522,6.01053942448139e-10
ACTN2,Alpha-actinin-2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37021,-0.0136630772859547,0.0060027839132101,-0.0254285337558465,-0.00189762081606288,0.0228546128485152
ACTN2,Alpha-actinin-2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37021,0.0315521765613628,0.00611670384510525,0.0195634370249565,0.0435409160977691,2.52738730760894e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37021,0.0213741046968627,0.00591132374011384,0.0097879101662396,0.0329602992274859,0.000300552010728982
ACTN2,Alpha-actinin-2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37021,0.0414444462791709,0.00600201136121963,0.0296805040111805,0.0532083885471614,5.2473123909106e-12
ACTN2,Alpha-actinin-2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37021,-0.0329854298318694,0.00578526305989016,-0.0443245454292542,-0.0216463142344847,1.21216997543894e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37021,-0.0142570057634005,0.00604942705740587,-0.026113882795916,-0.00240012873088504,0.0184500690429661
ACTN2,Alpha-actinin-2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37021,0.0215244484291999,0.0059219999853586,0.00991732845789702,0.0331315684005027,0.000279409506950759
ACTN2,Alpha-actinin-2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37021,0.0134887412781654,0.00566019672868032,0.00239475568995194,0.0245827268663788,0.0171822389943106
ACTN2,Alpha-actinin-2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37021,0.0392790163657155,0.00639543309147355,0.0267439675064273,0.0518140652250036,8.3978860562046e-10
ACTN2,Alpha-actinin-2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37021,-0.0239578795992823,0.00575305015329186,-0.0352338578997343,-0.0126819012988303,3.14191377274576e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37021,0.0352604025504355,0.00533597433015401,0.0248018928633337,0.0457189122375374,4.04399819829177e-11
ACTN2,Alpha-actinin-2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37021,-0.011959503645845,0.00535118257573373,-0.0224478214942831,-0.00147118579740689,0.0254388393326472
ACTN2,Alpha-actinin-2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37021,-0.017115336740937,0.00524876905972299,-0.0274029240979941,-0.00682774938387996,0.00111369626756376
ACTN2,Alpha-actinin-2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37021,0.0194236541550931,0.00586232956687604,0.00793348820401603,0.0309138201061701,0.000924509032044274
ACTN2,Alpha-actinin-2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37021,-0.0219606141535759,0.005887249393385,-0.0334996229646105,-0.0104216053425413,0.000192131948075796
ACTN2,Alpha-actinin-2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47284,0.000504063453635922,0.00455732427791136,-0.00842829213107035,0.00943641903834219,0.911930425239072
ACTN2,Alpha-actinin-2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47284,0.00116677429950365,0.00446407716564999,-0.00758281694517032,0.00991636554417763,0.793809755223953
ACTN2,Alpha-actinin-2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45557,0.00313321188638335,0.00429658878166647,-0.00528810212568294,0.0115545258984496,0.465867367314163
ACTN2,Alpha-actinin-2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45557,-0.00235879458588726,0.00465621462635468,-0.0114849752535424,0.00676738608176791,0.612447249267413
ACTN2,Alpha-actinin-2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45557,0.00289208325025321,0.0046168188399161,-0.00615688167598235,0.0119410481764888,0.531043870287207
ACTN2,Alpha-actinin-2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45557,0.00427003403057644,0.00425972505994637,-0.00407902708691844,0.0126190951480713,0.316151916314692
ACTN2,Alpha-actinin-2,Working and living environment,X24009.Traffic intensity on the nearest road,47284,0.0398300322178927,0.0429443236570268,-0.0443408421498798,0.124000906585665,0.353686554302018
ACTN2,Alpha-actinin-2,Working and living environment,X24010.Inverse distance to the nearest road,47284,0.00271065090207883,0.00399265537470479,-0.00511495363234255,0.0105362554365002,0.497202034500291
ACTN2,Alpha-actinin-2,Working and living environment,X24011.Traffic intensity on the nearest major road,47284,0.00223482252963886,0.00401943163125322,-0.00564326346761746,0.0101129085268952,0.578213011782282
ACTN2,Alpha-actinin-2,Working and living environment,X24012.Inverse distance to the nearest major road,47284,0.00609528322056881,0.00408713521391792,-0.00191550179871031,0.0141060682398479,0.135887324015204
ACTN2,Alpha-actinin-2,Working and living environment,X24013.Total traffic load on major roads,47284,0.0591634867568886,0.0297535559316854,0.000846517130785193,0.117480456382992,0.046773455741283
ACTN2,Alpha-actinin-2,Working and living environment,X24015.Sum of road length of major roads within 100m,47284,0.042935827479964,0.0289691281651736,-0.0138436637237762,0.0997153186837043,0.138320872746925
ACTN2,Alpha-actinin-2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47284,0.00453348441709243,0.00458263396017389,-0.00444847814484839,0.0135154469790332,0.322538915485209
ACTN2,Alpha-actinin-2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47284,0.00381001261530645,0.00457983212352932,-0.00516645834681102,0.0127864835774239,0.405467676192406
ACTN2,Alpha-actinin-2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47284,0.00486360381093781,0.0045361607926968,-0.00402727134274791,0.0137544789646235,0.283647967602418
ACTN2,Alpha-actinin-2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47242,0.00635963511471891,0.00438384396633076,-0.00223269905928939,0.0149519692887272,0.146877295602137
ACTN2,Alpha-actinin-2,Working and living environment,X24020.Average daytime sound level of noise pollution,47284,0.00736130033829391,0.00399952021420387,-0.000477759281545675,0.0152003599581335,0.0657007802611415
ACTN2,Alpha-actinin-2,Working and living environment,X24021.Average evening sound level of noise pollution,47284,0.00732575717598584,0.00399927535328781,-0.00051282251645827,0.01516433686843,0.0669982158902742
ACTN2,Alpha-actinin-2,Working and living environment,X24022.Average night-time sound level of noise pollution,47284,0.00736371534341494,0.00399965967502625,-0.000475617619636519,0.0152030483064664,0.065621671493806
ACTN2,Alpha-actinin-2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47284,0.00734128999313861,0.00399955918147084,-0.000497846002544235,0.0151804259888214,0.0664406406980775
ACTN2,Alpha-actinin-2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47284,0.00731763521605555,0.00399974056869041,-0.000521856298577652,0.0151571267306888,0.0673333329548631
ACTN2,Alpha-actinin-2,Health and medical history,X2405.Number of children fathered,34312,0.00261221302442854,0.0297464642217365,-0.055690856850175,0.0609152828990321,0.930024669263055
ACTN2,Alpha-actinin-2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44472,-0.00231742358222447,0.00475656714241201,-0.011640295181352,0.00700544801690308,0.626118200657632
ACTN2,Alpha-actinin-2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44472,0.00010377543723981,0.00433475530924914,-0.00839234496888849,0.00859989584336811,0.980900443051531
ACTN2,Alpha-actinin-2,Working and living environment,"X24502.Water percentage, buffer 1000m",44472,-0.00280208069025025,0.00422226845201528,-0.0110777268562002,0.0054735654756997,0.506925980383928
ACTN2,Alpha-actinin-2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44472,0.000374680005057685,0.00449569375256209,-0.00843687974996402,0.00918623976007939,0.933580432919025
ACTN2,Alpha-actinin-2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44472,-0.000382293355506807,0.00439915073041789,-0.00900462878712587,0.00824004207611226,0.93075055046195
ACTN2,Alpha-actinin-2,Working and living environment,"X24505.Water percentage, buffer 300m",44472,0.00263009346627096,0.00425259584242335,-0.00570499438487882,0.0109651813174207,0.536273871181155
ACTN2,Alpha-actinin-2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47369,-0.0027184628556883,0.00449823610554449,-0.0115350056225555,0.00609807991117889,0.545623619958619
ACTN2,Alpha-actinin-2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47369,-0.00488798145102507,0.00424632149304311,-0.0132107715773896,0.00343480867533943,0.249698854897603
ACTN2,Alpha-actinin-2,Working and living environment,X24508.Distance (Euclidean) to coast,47369,0.00472475570484028,0.0040580420862198,-0.00322900678415053,0.0126785181938311,0.244316537527028
ACTN2,Alpha-actinin-2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,27953,-0.0342682376602098,0.0547066395544554,-0.141493251186942,0.0729567758665228,0.531087557928342
ACTN2,Alpha-actinin-2,Health and medical history,X2704.Years since last cervical smear test,33780,-0.0443686359309821,0.0332519760148155,-0.109542508920021,0.0208052370580562,0.182131019625856
ACTN2,Alpha-actinin-2,Health and medical history,X2714.Age when periods started (menarche),36598,-0.0210567336471244,0.0299421010028262,-0.0797432516126639,0.037629784318415,0.481913834590928
ACTN2,Alpha-actinin-2,Health and medical history,X2734.Number of live births,36999,-0.00224864616872749,0.0284840939790412,-0.0580774703676483,0.0535801780301933,0.937078428265147
ACTN2,Alpha-actinin-2,Health and medical history,X2744.Birth weight of first child,33761,-0.00153711776930072,0.0325258868113787,-0.0652878559196029,0.0622136203810015,0.962308325129404
ACTN2,Alpha-actinin-2,Health and medical history,X2754.Age at first live birth,32042,0.00157103399540547,0.00620455163089272,-0.0105898872011443,0.0137319551919552,0.800114855969667
ACTN2,Alpha-actinin-2,Health and medical history,X2764.Age at last live birth,32019,0.00803212972689762,0.00621710526905198,-0.00415339660044426,0.0202176560542395,0.196414359295206
ACTN2,Alpha-actinin-2,Health and medical history,X2794.Age started oral contraceptive pill,35052,-0.000940269463629968,0.00613403295660777,-0.0129629740585812,0.0110824351313213,0.878174464085877
ACTN2,Alpha-actinin-2,Health and medical history,X2804.Age when last used oral contraceptive pill,34028,-0.00686635411843876,0.00540145387558533,-0.017453203714586,0.00372049547770849,0.203684873841307
ACTN2,Alpha-actinin-2,Lifestyle factors,X2867.Age started smoking in former smokers,28500,0.0201207814409984,0.00882283672739175,0.00282802145531054,0.0374135414266862,0.0226211682417695
ACTN2,Alpha-actinin-2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34127,0.00512570929202329,0.036953049259188,-0.0673022672559852,0.0775536858400317,0.889683066710056
ACTN2,Alpha-actinin-2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34124,-0.0485807182042281,0.0418279248175563,-0.130563450846638,0.0334020144381822,0.245489118296289
ACTN2,Alpha-actinin-2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34141,-0.0861354845901034,0.0429975649861601,-0.170410711962977,-0.00186025721722954,0.0451751368696147
ACTN2,Alpha-actinin-2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34114,-0.0426420796702535,0.0412816548654971,-0.123554123206628,0.0382699638661208,0.301649461766045
ACTN2,Alpha-actinin-2,Mental health,X28739.Difficulty with standing for long periods,34158,-0.00943206740006822,0.0384109240606359,-0.0847174785589147,0.0658533437587782,0.806030152135031
ACTN2,Alpha-actinin-2,Mental health,X28740.Difficulty with taking care of household responsibilities,34175,-0.0481783878772775,0.044028045570786,-0.134473357196018,0.038116581441463,0.273863945725042
ACTN2,Alpha-actinin-2,Mental health,X28741.Difficulty learning a new task,34097,0.0798521309718207,0.0470672226743309,-0.0123996254698679,0.172103887413509,0.089811238345667
ACTN2,Alpha-actinin-2,Mental health,X28742.Difficulty with joining in community activities,33730,-0.0215199011848168,0.0467415008210982,-0.113133242794169,0.0700934404245357,0.645237527076551
ACTN2,Alpha-actinin-2,Mental health,X28743.Difficulty with being emotionally affected by health problems,34100,-0.0317180437396983,0.0402032944390495,-0.110516500840235,0.0470804133608387,0.430164522740392
ACTN2,Alpha-actinin-2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34172,0.0205332955322396,0.0535213237865129,-0.0843684990893256,0.125435090153805,0.701248008217217
ACTN2,Alpha-actinin-2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28373,0.00261240215688904,0.0491619741266206,-0.0937450671312874,0.0989698714450655,0.957623769366893
ACTN2,Alpha-actinin-2,Lifestyle factors,X2897.Age stopped smoking,28502,-0.00509764031534066,0.0106555705670768,-0.0259825586268111,0.0157872779961298,0.632387038064376
ACTN2,Alpha-actinin-2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33033,4.02962659962429e-05,0.0129102690768165,-0.025263831124564,0.0253444236565565,0.997509669252686
ACTN2,Alpha-actinin-2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33033,-0.0145744646460409,0.0138433339237672,-0.0417073991366245,0.0125584698445428,0.292453684665979
ACTN2,Alpha-actinin-2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33033,-0.0537376428296345,0.0468134095745445,-0.145491925595742,0.0380166399364727,0.251035109640195
ACTN2,Alpha-actinin-2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33033,-0.0826607585839449,0.0463412336939681,-0.173489576624123,0.00816805945623265,0.0744988092162753
ACTN2,Alpha-actinin-2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33033,0.0258657891003067,0.049046159468503,-0.0702646834579592,0.121996261658573,0.597944953752513
ACTN2,Alpha-actinin-2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33033,0.0278133486179525,0.0416412116155389,-0.0538034261485038,0.109430123384409,0.504196090387742
ACTN2,Alpha-actinin-2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33033,0.0104229635963305,0.0192753494554011,-0.0273567213362556,0.0482026485289167,0.588699535320522
ACTN2,Alpha-actinin-2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33033,0.00626996115532395,0.0349558132916873,-0.0622434328963831,0.074783355207031,0.857652564252001
ACTN2,Alpha-actinin-2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32983,-0.0720367005552905,0.0434044908463301,-0.157109502614097,0.0130361015035164,0.0970172329960286
ACTN2,Alpha-actinin-2,Mental health,X29003.Recent feelings of depression,32981,-0.0126178910648524,0.0409066077075882,-0.0927948421717253,0.0675590600420206,0.757742375638315
ACTN2,Alpha-actinin-2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32988,-0.0177367359591445,0.0336003110482363,-0.0835933456136876,0.0481198736953986,0.597599514891405
ACTN2,Alpha-actinin-2,Mental health,X29005.Recent feelings of tiredness or low energy,32994,-0.0788607450881449,0.0340505132282437,-0.145599751015503,-0.0121217391607872,0.0205806936776559
ACTN2,Alpha-actinin-2,Mental health,X29006.Recent poor appetite or overeating,32996,0.00980583528512243,0.0444949851414369,-0.0774043355920939,0.0970160061623387,0.825579612469342
ACTN2,Alpha-actinin-2,Mental health,X29007.Recent feelings of inadequacy,32963,0.00855090572643518,0.0433495258243245,-0.0764141648892409,0.0935159763421113,0.843632487254391
ACTN2,Alpha-actinin-2,Mental health,X29008.Recent trouble concentrating on things,32993,0.0427096803877158,0.0427725499895757,-0.0411245175918526,0.126543878367284,0.318048816365054
ACTN2,Alpha-actinin-2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32984,-0.022091134408359,0.0786262797313004,-0.176198642681708,0.13201637386499,0.778744575771611
ACTN2,Alpha-actinin-2,Mental health,X29010.Recent thoughts of suicide or self-harm,32929,-0.0360758523422694,0.0848632835064724,-0.202407888014955,0.130256183330417,0.67076982435258
ACTN2,Alpha-actinin-2,Mental health,X29038#0.Substances taken for depression_None of options listed,31313,-0.0276983726633066,0.0249225112991414,-0.0765464948096237,0.0211497494830104,0.266440804826065
ACTN2,Alpha-actinin-2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31313,-0.000402238189657072,0.043411889897406,-0.0854895423885728,0.0846850660092586,0.992607456524663
ACTN2,Alpha-actinin-2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31313,-0.0306226017883687,0.0246395802093678,-0.0789161789987296,0.0176709754219922,0.213972689812434
ACTN2,Alpha-actinin-2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31313,-0.00736282991027477,0.0712580186053316,-0.147028546376725,0.132302886556175,0.917706755086591
ACTN2,Alpha-actinin-2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31313,-0.00943177558479183,0.0421979059340562,-0.092139671215542,0.0732761200459583,0.823142483916569
ACTN2,Alpha-actinin-2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31313,-0.0483558315457206,0.0455988444387154,-0.137729566645603,0.0410179035541616,0.288968934727311
ACTN2,Alpha-actinin-2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31313,0.0173689993978296,0.0534675399283851,-0.0874273788618052,0.122165377657464,0.745302740517136
ACTN2,Alpha-actinin-2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31313,-0.0248927541246219,0.0611031952192979,-0.144655016754446,0.0948695085052021,0.683734191001035
ACTN2,Alpha-actinin-2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31313,0.0207582825508048,0.0491123912986967,-0.0755020043946407,0.11701856949625,0.672549011001775
ACTN2,Alpha-actinin-2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31313,-0.00877648601673779,0.0251912776073137,-0.0581513901270726,0.0405984180935971,0.727554266050383
ACTN2,Alpha-actinin-2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31313,-0.0446950593833635,0.036627436642732,-0.116484835203118,0.0270947164363912,0.222404278607101
ACTN2,Alpha-actinin-2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31313,-0.0157514853621326,0.0580818148772409,-0.129591842521525,0.0980888717972594,0.786248733434751
ACTN2,Alpha-actinin-2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31313,-0.188613190000372,0.0721636374479295,-0.330053919398314,-0.0471724606024307,0.00897510048021265
ACTN2,Alpha-actinin-2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31313,-0.0481379488487691,0.0462127928169686,-0.138715022770028,0.0424391250724894,0.297603819773816
ACTN2,Alpha-actinin-2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31313,-0.197548793843439,0.0742633240979143,-0.343104909075351,-0.0519926786115266,0.00782817815234392
ACTN2,Alpha-actinin-2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31313,-0.173106356437997,0.070289553623949,-0.310873881540937,-0.0353388313350571,0.0138096351012693
ACTN2,Alpha-actinin-2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31313,-0.0499205731487094,0.0387111433363599,-0.125794414087975,0.0259532677905559,0.197241413059774
ACTN2,Alpha-actinin-2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31313,-0.0375298479506641,0.0379998939557283,-0.112009640103892,0.0369499442025635,0.323365785841448
ACTN2,Alpha-actinin-2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31313,-0.0584429538004754,0.0541755890371523,-0.164627108313294,0.0477412007123432,0.280725564550845
ACTN2,Alpha-actinin-2,Mental health,X29058.Recent feelings or nervousness or anxiety,32846,-0.00976688346097655,0.03915580580098,-0.0865122628308973,0.0669784959089442,0.803028929741066
ACTN2,Alpha-actinin-2,Mental health,X29059.Recent inability to stop or control worrying,32850,-0.0173347960990927,0.0413615023794005,-0.0984033407627177,0.0637337485645323,0.675149701077099
ACTN2,Alpha-actinin-2,Mental health,X29060.Recent worrying too much about different things,32845,-0.0123984591702474,0.0378141987800896,-0.086514288779223,0.0617173704387282,0.743011243799768
ACTN2,Alpha-actinin-2,Mental health,X29061.Recent trouble relaxing,32850,-0.0134173078674017,0.0395852380182781,-0.0910043743832267,0.0641697586484234,0.734657381144358
ACTN2,Alpha-actinin-2,Mental health,X29062.Recent restlessness,32852,-0.0197192031498663,0.0551494382480137,-0.127812102115973,0.0883736958162405,0.720681417810628
ACTN2,Alpha-actinin-2,Mental health,X29063.Recent easy annoyance or irritability,32837,-0.00918010271607491,0.0398010439625034,-0.0871901488825815,0.0688299434504317,0.81759213510732
ACTN2,Alpha-actinin-2,Mental health,X29064.Recent feelings of foreboding,32829,0.0313271184176751,0.0452657666335742,-0.0573937841841304,0.120048021019481,0.488910744674831
ACTN2,Alpha-actinin-2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31313,-0.0672069191475611,0.0254139351324866,-0.117018232007235,-0.0173956062878873,0.00819854038564791
ACTN2,Alpha-actinin-2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31313,-0.0412167804628669,0.0412479686257861,-0.122062798969408,0.0396292380436739,0.317709001634888
ACTN2,Alpha-actinin-2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31313,-0.0623096589157475,0.0553108948232304,-0.170719012769279,0.0460996949377841,0.259975404675061
ACTN2,Alpha-actinin-2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31313,0.0120677421494367,0.0602950149523381,-0.106110487157146,0.130245971456019,0.841372687975521
ACTN2,Alpha-actinin-2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31313,-0.05900056277526,0.0384290004187384,-0.134321403595987,0.0163202780454674,0.124749289650018
ACTN2,Alpha-actinin-2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31313,-0.0633204306461759,0.0414325180816308,-0.144528166086172,0.0178873047938204,0.126485818137721
ACTN2,Alpha-actinin-2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31313,0.0029459478494419,0.0413518777906968,-0.0781037326203238,0.0839956283192076,0.943207887047904
ACTN2,Alpha-actinin-2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31313,-0.0686644920453819,0.0379899147187924,-0.143124724894215,0.00579574080345126,0.0707340027557378
ACTN2,Alpha-actinin-2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31313,-0.118461759279897,0.0500018042823915,-0.216465295673384,-0.0204582228864096,0.0178543761972938
ACTN2,Alpha-actinin-2,Mental health,X29076.Felt loved as a child,32813,-0.0550743083459984,0.0345133311304125,-0.122720437361607,0.0125718206696101,0.110582126360849
ACTN2,Alpha-actinin-2,Mental health,X29077.Physically abused by family as a child,32818,0.0976306200327716,0.0434802778106754,0.0124092755238479,0.182851964541695,0.0247667542375966
ACTN2,Alpha-actinin-2,Mental health,X29078.Felt hated by family member as a child,32805,-0.0173338110622485,0.0464930655201811,-0.108460219481803,0.0737925973573064,0.709286988603073
ACTN2,Alpha-actinin-2,Mental health,X29079.Sexually molested as a child,32742,0.000321535229090401,0.0637495376359982,-0.124627558537466,0.125270628995647,0.995975818909503
ACTN2,Alpha-actinin-2,Mental health,X29080.Someone to take to doctor when needed as a child,32803,-0.0706636924856203,0.0509013593845753,-0.170430356879388,0.0291029719081473,0.165096238333482
ACTN2,Alpha-actinin-2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32804,-0.134466139968886,0.0679915617529223,-0.267729601004613,-0.00120267893315792,0.0479944928431449
ACTN2,Alpha-actinin-2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32757,-0.0576202699756174,0.0517516932303084,-0.159053588707022,0.043813048755787,0.265567299080629
ACTN2,Alpha-actinin-2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32811,0.0612349694844815,0.0548160584986385,-0.04620450517285,0.168674444141813,0.263981943406106
ACTN2,Alpha-actinin-2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32780,-0.0290417872002051,0.084984840579611,-0.195612074736243,0.137528500335833,0.732562873531406
ACTN2,Alpha-actinin-2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32779,0.00507253905133322,0.0797746128567897,-0.151285702147975,0.161430780250641,0.949301399294143
ACTN2,Alpha-actinin-2,Mental health,X29086.Experienced a violent or sexual assault,32810,-0.0102821380049892,0.0619487958624624,-0.131701777895416,0.111137501885437,0.868178003221651
ACTN2,Alpha-actinin-2,Mental health,X29087.Experienced a life-threatening injury or illness,32819,-0.00830801213703895,0.0421268075979946,-0.0908765550291083,0.0742605307550304,0.843664254250809
ACTN2,Alpha-actinin-2,Mental health,X29088.Experienced a marital separation or divorce,32819,0.0099418362904914,0.0380849278315022,-0.0647046222592529,0.0845882948402357,0.794064690547139
ACTN2,Alpha-actinin-2,Mental health,X29089.Experienced the death of a spouse or partner,32828,-0.00863940502715374,0.0622577217230539,-0.130664539604339,0.113385729550032,0.88963627407964
ACTN2,Alpha-actinin-2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32816,0.0187333843298579,0.0466208596433118,-0.0726435005710332,0.110110269230749,0.687823083803178
ACTN2,Alpha-actinin-2,Lifestyle factors,X29091.Frequency of drinking alcohol,32822,-0.0171603128315236,0.0320022341343028,-0.0798846917347571,0.04556406607171,0.591818209598025
ACTN2,Alpha-actinin-2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31892,-0.0398686573974302,0.0353853716887962,-0.109223985907471,0.0294866711126102,0.259903503600108
ACTN2,Alpha-actinin-2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31905,-0.0416045487504701,0.0350397158855719,-0.110282391886191,0.0270732943852508,0.235123063968648
ACTN2,Alpha-actinin-2,Mental health,X29104.Ever used cannabis,32812,-0.00620206989148469,0.0419802624664767,-0.0884833843257791,0.0760792445428097,0.882553059717186
ACTN2,Alpha-actinin-2,Mental health,X29108.Ever thought that life not worth living,32776,-0.00281456865284939,0.038835354095007,-0.0789318626790631,0.0733027253733643,0.942226010384167
ACTN2,Alpha-actinin-2,Mental health,X29109.Ever contemplated self-harm,32786,-0.0571822836328603,0.0515948136532041,-0.15830811839314,0.0439435511274197,0.267764218735779
ACTN2,Alpha-actinin-2,Mental health,X29111.Ever self-harmed,32805,-0.129586871352595,0.0854284819606468,-0.297026695995463,0.0378529532902724,0.129326072072308
ACTN2,Alpha-actinin-2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32811,-0.0416509059235275,0.0555559243460032,-0.150540517641694,0.0672387057946387,0.453448287942538
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,31858,-0.00195708163164992,0.0519305709850839,-0.103741000762414,0.0998268374991146,0.969938577765963
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,31858,-0.0190440526668711,0.0414887139081707,-0.100361931926886,0.0622738265931436,0.646233953165306
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,31858,-0.0550365556429166,0.0426787353343902,-0.138686876898321,0.0286137656124882,0.197242667693631
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,31858,0.00813889870847926,0.0569564388363684,-0.103495721410803,0.119773518827761,0.886375204261615
ACTN2,Alpha-actinin-2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32801,0.0152547913453812,0.0355492478922448,-0.0544217345234186,0.084931317214181,0.667848324506108
ACTN2,Alpha-actinin-2,Health and medical history,X29153.Pain or discomfort today,32814,-0.0126662764654099,0.0340118978079974,-0.0793295961690848,0.053997043238265,0.709598492465087
ACTN2,Alpha-actinin-2,Mental health,X29154.Anxiety or depression today,32814,-0.0374821484731519,0.0425986075992259,-0.120975419367635,0.0460111224213309,0.378941765942106
ACTN2,Alpha-actinin-2,Mental health,X29166.Frequency of confiding in someone close,32612,-0.00533823811788452,0.0328609428963484,-0.0697456861947273,0.0590692099589583,0.870955779918782
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32786,-0.0124996473409513,0.0134500476817291,-0.0388617407971402,0.0138624461152377,0.352738812037953
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32786,0.0223917898329717,0.0133739975608099,-0.00382124538621563,0.048604825052159,0.0941110108762199
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32786,0.00162715038615752,0.0167562369752754,-0.0312150740853823,0.0344693748576973,0.922643484503271
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32786,-0.0126727272196743,0.0196629887599997,-0.0512121851892737,0.0258667307499251,0.519270095468885
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32786,-0.0244984905842532,0.0304445232360261,-0.0841697561268644,0.035172774958358,0.421018370950764
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32786,0.000519930541386985,0.0143969970205621,-0.0276981836189148,0.0287380447016888,0.97119241127965
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32782,-0.0194633245809084,0.015719515556696,-0.0502735750720327,0.0113469259102158,0.215688158001403
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32782,0.0368086873999164,0.0223022258248529,-0.00690367521679519,0.080521050016628,0.0988863241977491
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32782,-0.0974464724345044,0.0358150469558434,-0.167643964467957,-0.0272489804010514,0.00652454869408237
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32782,0.00849128294576632,0.0353810539389791,-0.0608555827746327,0.0778381486661653,0.810339494962335
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32782,-0.00377338907010924,0.0477276276562047,-0.0973195392762705,0.089772761136052,0.936985958580234
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32782,0.0264235606566128,0.0233055984957532,-0.0192554123950635,0.0721025337082891,0.256914799623849
ACTN2,Alpha-actinin-2,Mental health,X29171.Frequency of feeling 'in tune' with people,32631,0.0287072426279611,0.0404863113567751,-0.0506459276313182,0.10806041288724,0.478305805684201
ACTN2,Alpha-actinin-2,Mental health,X29172.Freuency of feeling that lacks companionship,32742,-0.0530686499150895,0.0372572512821484,-0.1260928624281,0.0199555625979214,0.154370344802203
ACTN2,Alpha-actinin-2,Mental health,X29173.Frequency of feeling left out,32699,-0.0212738141102671,0.037964995955341,-0.0956852061827355,0.0531375779622013,0.575252621897789
ACTN2,Alpha-actinin-2,Mental health,X29174.Frequency of feeling isolated from others,32728,-0.0197671217608793,0.0392685610740548,-0.0967335014660268,0.0571992579442682,0.614707603054551
ACTN2,Alpha-actinin-2,Mental health,X29175.Tendency to bounce back quickly after hard times,32799,0.0054274298254516,0.0331072506530892,-0.0594627814546033,0.0703176411055065,0.869786195149993
ACTN2,Alpha-actinin-2,Mental health,X29176.Ability to make it through stressful events,32799,-0.0539803991377642,0.0321729014102999,-0.117039285901952,0.00907848762642365,0.0934168393049128
ACTN2,Alpha-actinin-2,Mental health,X29177.Quick recovery from stressful events,32799,0.0636404595548054,0.0326977547975367,-0.000447139848366487,0.127728058957977,0.0516470054172782
ACTN2,Alpha-actinin-2,Mental health,X29178.Hard to snap back when something bad happens,32799,-0.0339094997196159,0.0319965024758541,-0.0966226445722899,0.0288036451330581,0.289269838559161
ACTN2,Alpha-actinin-2,Mental health,X29179.Comes through difficult times with little trouble,32799,0.073885434991815,0.0328238555128691,0.00955067818659161,0.138220191797038,0.0244117935211871
ACTN2,Alpha-actinin-2,Mental health,X29180.Tendency to take a long time to get over setbacks,32799,-0.0314138095408995,0.0326404720982415,-0.0953891348534529,0.0325615157716539,0.335865230016725
ACTN2,Alpha-actinin-2,Mental health,X29181.General happiness,32743,-0.00956500859386984,0.0341425517437509,-0.0764844100116217,0.057354392823882,0.779369564677014
ACTN2,Alpha-actinin-2,Mental health,X29182.Belief that own life is meaningful,32659,0.0411577296253916,0.0337109751106109,-0.0249157815914057,0.107231240842189,0.222156608714105
ACTN2,Alpha-actinin-2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28104,-0.0488085327286946,0.0465745287572735,-0.140094609092951,0.0424775436355614,0.294713862066358
ACTN2,Alpha-actinin-2,Health and medical history,X2946.Father's age,32427,-0.000275674425864444,0.0100787775351111,-0.0200300783946823,0.0194787295429534,0.978179642967927
ACTN2,Alpha-actinin-2,Health and medical history,X2966.Age high blood pressure diagnosed,28218,-0.00472396117635318,0.0156086207750021,-0.0353168578953574,0.025868935542651,0.762170459263065
ACTN2,Alpha-actinin-2,Blood and urine assays,X30000.White blood cell (leukocyte) count,46867,0.0385611712935481,0.00418285106158943,0.0303627832128328,0.0467595593742634,3.25287450959072e-20
ACTN2,Alpha-actinin-2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,46867,-0.0295879303957667,0.00494918955086754,-0.0392883419154671,-0.0198875188760663,2.28747919887511e-09
ACTN2,Alpha-actinin-2,Blood and urine assays,X30020.Haemoglobin concentration,46867,-0.0322348650535625,0.00528413578141496,-0.0425917711851359,-0.0218779589219892,1.07552396308699e-09
ACTN2,Alpha-actinin-2,Blood and urine assays,X30030.Haematocrit percentage,46867,-0.0326722914276547,0.00517958367496067,-0.0428242754305776,-0.0225203074247318,2.87996943108377e-10
ACTN2,Alpha-actinin-2,Blood and urine assays,X30040.Mean corpuscular volume,46867,0.00409562747038014,0.00418326289125018,-0.00410356779647021,0.0122948227372305,0.327565104603036
ACTN2,Alpha-actinin-2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,46866,0.00621363615741256,0.00419320032868424,-0.00200503648680855,0.0144323088016337,0.138397573167146
ACTN2,Alpha-actinin-2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,46866,0.00156895325717931,0.00410086692694995,-0.00646874591964259,0.00960665243400121,0.702026853890151
ACTN2,Alpha-actinin-2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,46867,0.0102699006373231,0.00399416027857948,0.0024413464913073,0.0180984547833389,0.0101400539165494
ACTN2,Alpha-actinin-2,Blood and urine assays,X30080.Platelet count,46867,-0.0106332509622817,0.00421952000587459,-0.0189035101737959,-0.00236299175076751,0.0117417162111286
ACTN2,Alpha-actinin-2,Blood and urine assays,X30090.Platelet crit,46867,-0.0092182892964155,0.00432369552926899,-0.0176927325337827,-0.000743846059048274,0.0330141675588537
ACTN2,Alpha-actinin-2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,46867,0.00568733158349858,0.00406140111841483,-0.00227301460859449,0.0136476777755916,0.161425813700584
ACTN2,Alpha-actinin-2,Blood and urine assays,X30110.Platelet distribution width,46867,-0.000447332324385512,0.00403075181739451,-0.00834760588647875,0.00745294123770773,0.911633275288341
ACTN2,Alpha-actinin-2,Blood and urine assays,X30120.Lymphocyte count,46836,0.0186819107681368,0.00425972581594473,0.0103328481688851,0.0270309733673885,1.16123234360965e-05
ACTN2,Alpha-actinin-2,Blood and urine assays,X30130.Monocyte count,46836,0.0318022559801163,0.00425942573881549,0.023453781532038,0.0401507304281947,8.53997500179454e-14
ACTN2,Alpha-actinin-2,Blood and urine assays,X30140.Neutrophill count,46836,0.033234531335053,0.0041544443325292,0.0250918204432958,0.0413772422268103,1.30518930767721e-15
ACTN2,Alpha-actinin-2,Blood and urine assays,X30150.Eosinophill count,46836,0.000680706342278277,0.00405975053733672,-0.00727640471090169,0.00863781739545824,0.866842829800094
ACTN2,Alpha-actinin-2,Blood and urine assays,X30160.Basophill count,46836,0.0376433392492251,0.0221159743377061,-0.00570397045267896,0.0809906489511291,0.0887523615777464
ACTN2,Alpha-actinin-2,Blood and urine assays,X30170.Nucleated red blood cell count,46836,0.0187851110739623,0.097554330176477,-0.172421376071932,0.209991598219857,0.847304880449109
ACTN2,Alpha-actinin-2,Blood and urine assays,X30180.Lymphocyte percentage,46836,-0.013072720422171,0.00419647817167556,-0.0212978176386551,-0.00484762320568687,0.00184068489271575
ACTN2,Alpha-actinin-2,Blood and urine assays,X30190.Monocyte percentage,46836,0.00342101101957275,0.00420492017594701,-0.00482063252528339,0.0116626545644289,0.4158978375388
ACTN2,Alpha-actinin-2,Blood and urine assays,X30200.Neutrophill percentage,46836,0.0120377092998197,0.00413012062813828,0.00394267286866871,0.0201327457309708,0.00356471849476933
ACTN2,Alpha-actinin-2,Blood and urine assays,X30210.Eosinophill percentage,46836,-0.0127208111764812,0.0040034792804807,-0.0205676305662234,-0.00487399178673902,0.00148778586668848
ACTN2,Alpha-actinin-2,Blood and urine assays,X30220.Basophill percentage,46836,-0.00134389778651605,0.00399942523178114,-0.00918277124080709,0.00649497566777498,0.736856794093061
ACTN2,Alpha-actinin-2,Blood and urine assays,X30230.Nucleated red blood cell percentage,46836,0.0182434298372334,0.0978524805297442,-0.173547432001065,0.210034291675532,0.852102868469319
ACTN2,Alpha-actinin-2,Blood and urine assays,X30240.Reticulocyte percentage,46449,-0.00702005447037899,0.00429288544351206,-0.0154341099396626,0.00139400099890465,0.102005041051953
ACTN2,Alpha-actinin-2,Blood and urine assays,X30250.Reticulocyte count,46449,-0.0123957909901728,0.00440359555468918,-0.0210268382773636,-0.00376474370298203,0.00488308406681546
ACTN2,Alpha-actinin-2,Blood and urine assays,X30260.Mean reticulocyte volume,46449,-0.000511325556054014,0.00413835423396434,-0.00862249985462411,0.00759984874251608,0.901666580762578
ACTN2,Alpha-actinin-2,Blood and urine assays,X30270.Mean sphered cell volume,46449,0.00969096287130264,0.00415980370899431,0.00153774760167379,0.0178441781409315,0.0198324548290329
ACTN2,Alpha-actinin-2,Blood and urine assays,X30280.Immature reticulocyte fraction,46449,-0.00506036753551318,0.00432428045558001,-0.01353595722845,0.00341522215742364,0.241924042207059
ACTN2,Alpha-actinin-2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46449,-0.0079666646727368,0.00438886287206232,-0.0165688359019789,0.000635506556505339,0.0695064071125135
ACTN2,Alpha-actinin-2,Blood and urine assays,X30300.High light scatter reticulocyte count,46449,-0.0121199632780932,0.00446476815854681,-0.0208709088688449,-0.00336901768734141,0.00664105709330704
ACTN2,Alpha-actinin-2,Blood and urine assays,X30500.Microalbumin in urine,30757,0.0363273013262227,0.00787000719516287,0.0209020872237035,0.051752515428742,3.98446553895877e-06
ACTN2,Alpha-actinin-2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,46987,0.0078600971374161,0.00427236461897607,-0.000513737515777003,0.0162339317906092,0.0658172646560072
ACTN2,Alpha-actinin-2,Blood and urine assays,X30520.Potassium in urine,46940,-0.0121148136453823,0.00395580434675016,-0.0198681901650126,-0.00436143712575195,0.00219718849836662
ACTN2,Alpha-actinin-2,Blood and urine assays,X30530.Sodium in urine,46939,-0.00523431828005994,0.00412241089893003,-0.0133142436419628,0.00284560708184292,0.204196262304205
ACTN2,Alpha-actinin-2,Blood and urine assays,X30600.Albumin,44606,0.00186269680936453,0.00447961781374643,-0.00691735410557848,0.0106427477243075,0.677548942949365
ACTN2,Alpha-actinin-2,Blood and urine assays,X30610.Alkaline phosphatase,46518,-0.00587080553582001,0.00420918579657724,-0.0141208096971114,0.00237919862547138,0.163101786383919
ACTN2,Alpha-actinin-2,Blood and urine assays,X30620.Alanine aminotransferase,46509,0.0673008060621524,0.00443519378161478,0.0586078262501874,0.0759937858741173,9.41128453253251e-52
ACTN2,Alpha-actinin-2,Blood and urine assays,X30630.Apolipoprotein A,44482,0.0106364805801675,0.00489334171713473,0.00104553081458342,0.0202274303457516,0.0297417186317129
ACTN2,Alpha-actinin-2,Blood and urine assays,X30640.Apolipoprotein B,46369,-0.0304509122732225,0.00428712524567155,-0.0388536777547387,-0.0220481467917063,1.25826202123506e-12
ACTN2,Alpha-actinin-2,Blood and urine assays,X30650.Aspartate aminotransferase,46444,0.148771548168043,0.00405766823381184,0.140818518429772,0.156724577906314,6.34993186274921e-286
ACTN2,Alpha-actinin-2,Blood and urine assays,X30660.Direct bilirubin,42951,0.0101378886932106,0.00465985046267368,0.00100458178637022,0.019271195600051,0.0295987249608283
ACTN2,Alpha-actinin-2,Blood and urine assays,X30670.Urea,46513,0.0604979198486438,0.00438423010795901,0.0519048288370441,0.0690910108602435,3.86395135736151e-43
ACTN2,Alpha-actinin-2,Blood and urine assays,X30680.Calcium,44603,0.0221067059883775,0.00435421746857759,0.0135724397499654,0.0306409722267895,3.86597100462126e-07
ACTN2,Alpha-actinin-2,Blood and urine assays,X30690.Cholesterol,46523,-0.0218483264015843,0.00440105658026769,-0.030474397298909,-0.0132222555042596,6.94365115503907e-07
ACTN2,Alpha-actinin-2,Blood and urine assays,X30700.Creatinine,46517,0.0902518821751891,0.00533796615367217,0.0797894685139917,0.100714295836387,9.74147944507588e-64
ACTN2,Alpha-actinin-2,Blood and urine assays,X30710.C-reactive protein,46448,-0.000423180981446884,0.00456774865041548,-0.00937596833626123,0.00852960637336746,0.926186082437126
ACTN2,Alpha-actinin-2,Blood and urine assays,X30720.Cystatin C,46521,0.0627014465895388,0.00491886991632006,0.0530604615535515,0.0723424316255261,4.3377491474516e-37
ACTN2,Alpha-actinin-2,Blood and urine assays,X30730.Gamma glutamyltransferase,46514,-0.00538670795366933,0.00455078867773154,-0.0143062537620232,0.00353283785468449,0.236549532827247
ACTN2,Alpha-actinin-2,Blood and urine assays,X30740.Glucose,44572,-0.00848229748169683,0.00443626781670938,-0.0171773824024472,0.00021278743905356,0.0558855400746223
ACTN2,Alpha-actinin-2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46357,0.016403988759965,0.00442386991898395,0.0077332037187565,0.0250747738011736,0.000209352184950823
ACTN2,Alpha-actinin-2,Blood and urine assays,X30760.HDL cholesterol,44587,0.023575971121531,0.00516336793339553,0.0134557699720758,0.0336961722709863,4.9996170151928e-06
ACTN2,Alpha-actinin-2,Blood and urine assays,X30770.IGF-1,46415,0.0118347841724208,0.00432506461867631,0.00335765751981528,0.0203119108250264,0.00621781713456816
ACTN2,Alpha-actinin-2,Blood and urine assays,X30780.LDL direct,46473,-0.0290440534391238,0.00434903091048915,-0.0375681540236825,-0.020519952854565,2.47369553853568e-11
ACTN2,Alpha-actinin-2,Blood and urine assays,X30790.Lipoprotein A,42020,-0.00184009325451719,0.00456636274126255,-0.0107901642273918,0.00710997771835741,0.686977283639857
ACTN2,Alpha-actinin-2,Blood and urine assays,X30810.Phosphate,44553,0.0472693997260305,0.00435017677787975,0.0387430532413861,0.0557957462106748,1.98329505544237e-27
ACTN2,Alpha-actinin-2,Blood and urine assays,X30830.SHBG,44405,0.00571763311656288,0.00506185918654863,-0.00420361088907244,0.0156388771221982,0.258678238517263
ACTN2,Alpha-actinin-2,Blood and urine assays,X30840.Total bilirubin,46437,0.00820058279919691,0.00425659290451715,-0.000142339293656703,0.0165435048920505,0.0540469905418193
ACTN2,Alpha-actinin-2,Blood and urine assays,X30850.Testosterone,44699,-0.0353048293861388,0.00721790062095277,-0.0494519146032062,-0.0211577441690714,1.00925074813844e-06
ACTN2,Alpha-actinin-2,Blood and urine assays,X30860.Total protein,44590,-0.00613911785366893,0.00444406540656124,-0.014849486050529,0.0025712503431911,0.167164954726038
ACTN2,Alpha-actinin-2,Blood and urine assays,X30870.Triglycerides,46505,-0.0178540762234835,0.00435322561814275,-0.0263863984350433,-0.00932175401192373,4.12191615380098e-05
ACTN2,Alpha-actinin-2,Blood and urine assays,X30880.Urate,46497,0.0310016407365188,0.00527316364329568,0.0206662399956592,0.0413370414773783,4.18203031850856e-09
ACTN2,Alpha-actinin-2,Blood and urine assays,X30890.Vitamin D,45598,0.0318335927823446,0.00457594474971907,0.0228647410728952,0.040802444491794,3.5816083893854e-12
ACTN2,Alpha-actinin-2,Physical measures,X3137.Number of measurements made,45687,-0.000462054753599741,0.0251640459604688,-0.0497835848361186,0.0488594753289192,0.985350471216605
ACTN2,Alpha-actinin-2,Physical measures,X3143.Ankle spacing width,37288,0.0200861658808494,0.00735719314848507,0.0056660673098187,0.0345062644518802,0.00633900156036256
ACTN2,Alpha-actinin-2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37287,-0.00315449074844467,0.00561953964483396,-0.0141687884523192,0.0078598069554299,0.574572919058147
ACTN2,Alpha-actinin-2,Physical measures,X3146.Speed of sound through heel,37288,-0.0052863696963222,0.0054773670608259,-0.016022009135541,0.00544926974289656,0.334497227212234
ACTN2,Alpha-actinin-2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37288,-0.00474669279670294,0.00552482678278921,-0.0155753532909698,0.00608196769756391,0.390269320702444
ACTN2,Alpha-actinin-2,Physical measures,X3148.Heel bone mineral density (BMD),37278,-0.00461619721795967,0.005539645675069,-0.0154739027410949,0.00624150830517557,0.40468932250869
ACTN2,Alpha-actinin-2,Health and medical history,X3526.Mother's age at death,33480,-0.0125458968758725,0.00732951898031061,-0.0269117540772813,0.00181996032553632,0.0869852264227717
ACTN2,Alpha-actinin-2,Health and medical history,X3581.Age at menopause (last menstrual period),29361,-0.0117509945794147,0.0093383880897691,-0.0300542352353621,0.00655224607653278,0.208317287492125
ACTN2,Alpha-actinin-2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29303,-0.00420954388845308,0.0096468956491095,-0.0231174593607077,0.0146983715838015,0.662591020397431
ACTN2,Alpha-actinin-2,Physical measures,X4100.Ankle spacing width (left),31444,0.0213981647978257,0.0104004789539903,0.00101322604800467,0.0417831035476467,0.0396798498871277
ACTN2,Alpha-actinin-2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31444,-0.00256347801943377,0.00794368834475985,-0.0181331071751631,0.0130061511362955,0.746926600724767
ACTN2,Alpha-actinin-2,Physical measures,X4103.Speed of sound through heel (left),31444,0.00249681397386559,0.00776478843515982,-0.0127221713590477,0.0177157993067788,0.74779797600741
ACTN2,Alpha-actinin-2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31444,0.00093073136181524,0.007831075201893,-0.014418176033895,0.0162796387575255,0.905396526014897
ACTN2,Alpha-actinin-2,Physical measures,X4105.Heel bone mineral density (BMD) (left),31438,0.00102221692398979,0.00784283312182349,-0.0143497359947843,0.0163941698427638,0.896302704260038
ACTN2,Alpha-actinin-2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31444,0.000965697282521027,0.00783117488506184,-0.0143834054922002,0.0163148000572422,0.901861340250735
ACTN2,Alpha-actinin-2,Physical measures,X4119.Ankle spacing width (right),31435,0.0181461214468189,0.0102637117700709,-0.00197075362251998,0.0382629965161579,0.077103120681878
ACTN2,Alpha-actinin-2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31435,0.0016220458897125,0.00803001473166318,-0.0141167829843473,0.0173608747637723,0.839923811934015
ACTN2,Alpha-actinin-2,Physical measures,X4122.Speed of sound through heel (right),31435,0.00879325634303457,0.00780410537353724,-0.00650279018909843,0.0240893028751676,0.259884938337331
ACTN2,Alpha-actinin-2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31435,0.00674508098048774,0.00788717253316466,-0.008713777184515,0.0222039391454905,0.392469516659243
ACTN2,Alpha-actinin-2,Physical measures,X4124.Heel bone mineral density (BMD) (right),31428,0.00757143575745705,0.00790324881629802,-0.00791893192248706,0.0230618034374012,0.338085488750893
ACTN2,Alpha-actinin-2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31435,0.0067512918618238,0.00788724722087226,-0.00870771269108584,0.0222102964147334,0.392038302451908
ACTN2,Alpha-actinin-2,Physical measures,X4194.Pulse rate,31697,-0.00479261966199972,0.00750981246511839,-0.0195118520936318,0.00992661276963233,0.523374507805657
ACTN2,Alpha-actinin-2,Physical measures,X4195.Pulse wave reflection index,31697,-0.00473883081684538,0.00731989323591849,-0.0190858215592456,0.00960815992555485,0.517398074865831
ACTN2,Alpha-actinin-2,Physical measures,X4196.Pulse wave peak to peak time,31692,0.0161397803862587,0.00784215670774281,0.00076915323908275,0.0315104075334346,0.0396155366025104
ACTN2,Alpha-actinin-2,Physical measures,X4198.Position of the pulse wave peak,31697,-0.0114189476480538,0.00754170553481706,-0.0262006904962952,0.00336279520018768,0.130039080276746
ACTN2,Alpha-actinin-2,Physical measures,X4199.Position of pulse wave notch,31697,-0.00231372052626087,0.00742679993003106,-0.0168702483891218,0.0122428073366,0.755400956259158
ACTN2,Alpha-actinin-2,Physical measures,X4200.Position of the shoulder on the pulse waveform,31697,-0.0160535826259653,0.00772134503800394,-0.031187418900453,-0.000919746351477541,0.0376390058638305
ACTN2,Alpha-actinin-2,Physical measures,X4269.Number of triplets attempted (left),31571,-0.166316806491449,0.101998574998804,-0.366234013489106,0.0336004005062075,0.103019949123299
ACTN2,Alpha-actinin-2,Physical measures,X4270.Volume level set by participant (left),31495,-0.00648597170766571,0.0328204221197565,-0.0708139990623885,0.057842055647057,0.843347651196215
ACTN2,Alpha-actinin-2,Physical measures,X4276.Number of triplets attempted (right),31580,-0.0744421891843365,0.106424201837719,-0.283033624786266,0.134149246417593,0.484269763353794
ACTN2,Alpha-actinin-2,Physical measures,X4277.Volume level set by participant (right),31494,-0.00906408376395677,0.0326129811620313,-0.0729855268415381,0.0548573593136245,0.781074614356878
ACTN2,Alpha-actinin-2,Cognitive function,X4288.Time to answer,31720,0.0125546407549666,0.00859476405784657,-0.0042910967984127,0.0294003783083459,0.144129170470274
ACTN2,Alpha-actinin-2,Cognitive function,X4290.Duration screen displayed,31720,0.0109521239984567,0.00750512035826791,-0.00375791190374844,0.0256621599006618,0.144526114722502
ACTN2,Alpha-actinin-2,Physical measures,X46.Hand grip strength (left),47570,0.0350160074414371,0.00571364120139389,0.023817270686705,0.0462147441961691,9.01140899391999e-10
ACTN2,Alpha-actinin-2,Physical measures,X47.Hand grip strength (right),47549,0.0332594212780028,0.0056590536528502,0.0221676761184164,0.0443511664375892,4.22836267239457e-09
ACTN2,Alpha-actinin-2,Physical measures,X48.Waist circumference,47618,-0.00731117387298296,0.00893783892597038,-0.0248293381678849,0.010206990421919,0.413364009040243
ACTN2,Alpha-actinin-2,Health and medical history,X4803.Tinnitus,31528,-0.00426093635447078,0.0403977060477909,-0.083440440208141,0.0749185674991994,0.916001895984711
ACTN2,Alpha-actinin-2,Working and living environment,X4825.Noisy workplace,31654,0.0789597741557873,0.0422545604101029,-0.00385916424801434,0.161778712559589,0.061706414900151
ACTN2,Alpha-actinin-2,Working and living environment,X4836.Loud music exposure frequency,31601,0.00357683483991048,0.0469899444849731,-0.0885234563506369,0.0956771260304578,0.939326268919091
ACTN2,Alpha-actinin-2,Physical measures,X49.Hip circumference,47615,0.00365464897173493,0.00705491275962942,-0.0101729800371387,0.0174822779806086,0.604442902883857
ACTN2,Alpha-actinin-2,Physical measures,X50.Standing height,47593,0.0426161039037598,0.0056050990015075,0.0316301098608051,0.0536020979467145,2.99832993621036e-14
ACTN2,Alpha-actinin-2,Health and medical history,X5057.Number of older siblings,31001,-0.0162535985324231,0.0342463343314396,-0.0833764138220447,0.0508692167571984,0.635080620768366
ACTN2,Alpha-actinin-2,Physical measures,X51.Seated height,47480,0.0167914367710237,0.00519835873918154,0.00660265364222788,0.0269802198998195,0.00123898003235507
ACTN2,Alpha-actinin-2,Eye measures,X5181.Ever had eye surgery,29199,0.0675440590067162,0.0828118085750844,-0.0947670858004492,0.229855203813881,0.414746363341799
ACTN2,Alpha-actinin-2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29188,0.00138999416969523,0.00931498286547677,-0.0168673722466392,0.0196473605860297,0.88138463395512
ACTN2,Alpha-actinin-2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29187,0.0177501311160408,0.00921539084519778,-0.000312034940546827,0.0358122971726284,0.0541400709440671
ACTN2,Alpha-actinin-2,Eye measures,X5190.Duration at which refractometer first shown (right),29139,0.0219361240961541,0.0090763116654173,0.0041465532319362,0.039725694960372,0.0156889645277613
ACTN2,Alpha-actinin-2,Eye measures,X5193.Duration at which refractometer first shown (left),29138,0.0225614435731454,0.00911338975507979,0.00469919965318896,0.0404236874931017,0.013331027538544
ACTN2,Alpha-actinin-2,Eye measures,"X5199.logMAR, initial (right)",29164,0.0659935715845338,0.0400049583279509,-0.01241614673825,0.144403289907318,0.0990768779396608
ACTN2,Alpha-actinin-2,Eye measures,X5200.Final number of letters displayed (right),29164,-0.0268225118653937,0.294515247754203,-0.604072397463631,0.550427373732844,0.927437690286435
ACTN2,Alpha-actinin-2,Eye measures,"X5201.logMAR, final (right)",29121,0.0121550719449587,0.00881403157252423,-0.00512042993718879,0.0294305738271062,0.167935103848155
ACTN2,Alpha-actinin-2,Eye measures,X5202.Number of rounds to result (right),29164,-0.00127086359596909,0.0383064217977628,-0.0763514503195841,0.0738097231276459,0.973535284846846
ACTN2,Alpha-actinin-2,Eye measures,"X5206.logMAR, initial (left)",29164,0.0415708041141312,0.0401993583612513,-0.0372199382739213,0.120361546502184,0.30112904123369
ACTN2,Alpha-actinin-2,Eye measures,X5207.Final number of letters displayed (left),29164,-0.0639713064898609,0.278589541929905,-0.610006808672474,0.482064195692752,0.818391526058482
ACTN2,Alpha-actinin-2,Eye measures,"X5208.logMAR, final (left)",29121,0.0102640247371208,0.00893123603302464,-0.00724119788760755,0.027769247361849,0.250514303446002
ACTN2,Alpha-actinin-2,Eye measures,X5209.Number of rounds to result (left),29160,0.026402007437615,0.0389776597591592,-0.0499942056903371,0.102798220565567,0.498205572994973
ACTN2,Alpha-actinin-2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",28963,-0.0212067936216798,0.00912669682493274,-0.039095119398548,-0.00331846784481165,0.0201860271556834
ACTN2,Alpha-actinin-2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",28963,-0.033888138815362,0.00897158988888658,-0.0514724549975797,-0.0163038226331443,0.000160360272464923
ACTN2,Alpha-actinin-2,Eye measures,X5256.Corneal hysteresis (right),28963,-0.0124045594182446,0.00916480842971217,-0.0303675839404804,0.00555846510399128,0.175956204041705
ACTN2,Alpha-actinin-2,Eye measures,X5257.Corneal resistance factor (right),28963,-0.0287872351939247,0.00899676722321703,-0.04642089895143,-0.0111535714364193,0.00138398105853358
ACTN2,Alpha-actinin-2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",28942,-0.016542548516575,0.00922648512918666,-0.0346264593697809,0.00154136233663084,0.0730417180353484
ACTN2,Alpha-actinin-2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",28942,-0.0302875764145493,0.00906679803092551,-0.0480585005551633,-0.0125166522739353,0.000842328331617934
ACTN2,Alpha-actinin-2,Eye measures,X5264.Corneal hysteresis (left),28942,-0.0150322762606175,0.00917987579985951,-0.0330248328283421,0.00296028030710718,0.101582727803183
ACTN2,Alpha-actinin-2,Eye measures,X5265.Corneal resistance factor (left),28942,-0.0267624336229775,0.00903557571490865,-0.0444721620241985,-0.00905270522175656,0.00307166930850367
ACTN2,Alpha-actinin-2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,28979,0.120940670908062,0.137436807808022,-0.14843547239566,0.390316814211785,0.378915288804069
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47542,0.00338226180833241,0.023960590184895,-0.0435804949540618,0.0503450185707266,0.887745243521675
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47542,-0.00537964275157569,0.0265277434934654,-0.0573740199987679,0.0466147344956166,0.83929851074525
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47542,0.0319765095199641,0.0657916352948234,-0.0969750956578899,0.160928114697818,0.626952537169614
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47542,0.0199596225404045,0.0111934465916474,-0.00197953277922445,0.0418987778600333,0.0745742822413811
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47542,-0.020625487780177,0.0100378080388724,-0.040299591536367,-0.000951384023987131,0.0399111994432071
ACTN2,Alpha-actinin-2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35679,0.00178169243955282,0.0114833600120581,-0.0207256931840811,0.0242890780631867,0.876702341518767
ACTN2,Alpha-actinin-2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35679,0.0242408025341042,0.0396116504589596,-0.0533980323654565,0.101879637433665,0.540575043692891
ACTN2,Alpha-actinin-2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35679,0.0148079611049441,0.0196369634489023,-0.0236804872549045,0.0532964094647926,0.450812548735905
ACTN2,Alpha-actinin-2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35679,0.00491463339123225,0.0124187803143365,-0.0194261760248673,0.0292554428073318,0.692302485520577
ACTN2,Alpha-actinin-2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47609,-0.0141221056840408,0.0224617753407302,-0.058147185351872,0.0299029739837904,0.529540227712706
ACTN2,Alpha-actinin-2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47609,-0.0141221056840408,0.0224617753407302,-0.058147185351872,0.0299029739837904,0.529540227712706
ACTN2,Alpha-actinin-2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47609,-0.0272418003488143,0.0166397691050021,-0.0598557477946183,0.00537214709698976,0.101612350966113
ACTN2,Alpha-actinin-2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47609,0.0016225661064548,0.0259368782544371,-0.0492137152722418,0.0524588474851514,0.950118790347112
ACTN2,Alpha-actinin-2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47609,-0.066136394707715,0.0633490317506823,-0.190300496939052,0.0580277075236224,0.29649597544501
ACTN2,Alpha-actinin-2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47609,0.0215400718617602,0.0456501826331185,-0.0679342860991521,0.111014429822673,0.637037675149244
ACTN2,Alpha-actinin-2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47609,0.0326453935681381,0.0678726572609824,-0.100385014663387,0.165675801799664,0.630535114121821
ACTN2,Alpha-actinin-2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47541,-0.0224639655810321,0.0128331479843588,-0.0476169356303753,0.00268900446831112,0.0800512025810885
ACTN2,Alpha-actinin-2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47541,-0.0273815932763807,0.0220582030500745,-0.0706156712545267,0.0158524847017653,0.214494754514795
ACTN2,Alpha-actinin-2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47541,-0.0214755263513458,0.010757368416863,-0.0425599684483974,-0.000391084254294211,0.0459067229134829
ACTN2,Alpha-actinin-2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47541,0.0134651405683369,0.020171436404627,-0.026070874784732,0.0530011559214058,0.504436941561398
ACTN2,Alpha-actinin-2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47541,0.00100399553166116,0.0175685315787997,-0.0334303263627863,0.0354383174261086,0.954428277271307
ACTN2,Alpha-actinin-2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47541,-0.0111644381951715,0.0142113452070698,-0.0390186748010282,0.0166897984106852,0.432109501669401
ACTN2,Alpha-actinin-2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29096,0.0521787470110829,0.037352916909867,-0.0210329701322565,0.125390464154422,0.162499161572236
ACTN2,Alpha-actinin-2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29096,-0.018470094565646,0.0328725328709842,-0.0829002589927751,0.045960069861483,0.574228550596008
ACTN2,Alpha-actinin-2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29096,0.0471104457328092,0.0407218470210332,-0.032704374428416,0.126925265894034,0.247372608266491
ACTN2,Alpha-actinin-2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29096,-0.0183709971482669,0.0335268051012562,-0.084083535146729,0.0473415408501952,0.583749915068364
ACTN2,Alpha-actinin-2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47499,0.0205753576598616,0.035339155723269,-0.0486893875577456,0.0898401028774688,0.560420351064005
ACTN2,Alpha-actinin-2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47499,0.0698317282306227,0.0516388690593308,-0.0313804551256657,0.171043911586911,0.176289293646879
ACTN2,Alpha-actinin-2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47499,0.128370737026062,0.106446847165971,-0.0802650834192425,0.337006557471366,0.227844631814097
ACTN2,Alpha-actinin-2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47499,0.0936190920758806,0.0864751825445117,-0.0758722657113624,0.263110449863124,0.278991609833428
ACTN2,Alpha-actinin-2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47499,0.0150037769585666,0.032856066709809,-0.049394113792659,0.0794016677097923,0.647925646764343
ACTN2,Alpha-actinin-2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47499,-0.00487188450709328,0.0422475719627328,-0.0876771255540496,0.0779333565398631,0.908194444989691
ACTN2,Alpha-actinin-2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47499,0.072106607224141,0.0171660056531314,0.0384612361440034,0.105751978304279,2.67246796980831e-05
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32070,0.111424034345722,0.0337103346281954,0.0453517784744591,0.177496290216985,0.000952688903609847
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32070,0.0188792418839808,0.03773982074443,-0.0550908067751019,0.0928492905430635,0.61691439369759
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32070,0.0736269586222876,0.0481746958698265,-0.0207954452825724,0.168049362527148,0.12646850168217
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32070,0.0213676852034478,0.0145763146550913,-0.00720189152053115,0.0499372619274267,0.142708865205481
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",33856,0.0429204971143397,0.0153631269574662,0.0128087682777059,0.0730322259509734,0.00522024047420753
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",33856,-0.011604011071184,0.0124603345112576,-0.0360262667132488,0.0128182445708808,0.351733279662014
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",33856,-0.0258629643950912,0.0123067891244719,-0.0499842710790561,-0.00174165771112627,0.0356203022243228
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",33857,-0.0661030923116905,0.0296970623612778,-0.124309334539795,-0.00789685008358594,0.0260421843568588
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",33857,0.0247246432352506,0.0193183582986179,-0.0131393390300405,0.0625886255005417,0.200626822986768
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",33857,-0.0198967454348027,0.0245028533304476,-0.0679223379624799,0.0281288470928746,0.416800930609392
ACTN2,Alpha-actinin-2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47541,0.0396797003801219,0.0299376585400433,-0.0189981103583631,0.0983575111186068,0.185047674384164
ACTN2,Alpha-actinin-2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47541,0.0573219145468612,0.0192835053459926,0.0195262440687157,0.0951175850250066,0.00295597667363186
ACTN2,Alpha-actinin-2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47541,-0.0499070163017109,0.0599303419089584,-0.167370486443269,0.0675564538398476,0.404993910569767
ACTN2,Alpha-actinin-2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47541,0.0519012401258799,0.0219359537004022,0.00890677087309161,0.0948957093786681,0.0179877360244387
ACTN2,Alpha-actinin-2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47541,0.0636764943061138,0.0241392108449915,0.0163636410499305,0.110989347562297,0.00834790681849053
ACTN2,Alpha-actinin-2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47541,0.0474963370070526,0.0264085086936316,-0.00426434003246531,0.0992570140465704,0.0721067366056201
ACTN2,Alpha-actinin-2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47541,-0.0369729436425393,0.0086208215088906,-0.0538697537999649,-0.0200761334851137,1.80355530739272e-05
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27462,0.0614136621777683,0.0280212812591338,0.00649195090986607,0.11633537344567,0.0284664780397372
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27462,-0.0208588288785942,0.0357455240201801,-0.0909200559581471,0.0492023982009587,0.559568523430461
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27462,0.0144303937716207,0.0263557517586774,-0.037226879675387,0.0660876672186283,0.584053044582713
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27462,-0.0132231449081876,0.0220151518644643,-0.0563728425625376,0.0299265527461625,0.548118666173119
ACTN2,Alpha-actinin-2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47653,-0.035376582288629,0.00923448259931348,-0.0534761681832834,-0.0172769963939746,0.000127991712100787
ACTN2,Alpha-actinin-2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47653,-0.0429007124161348,0.0270724002033401,-0.0959626168146814,0.0101611919824119,0.113055528403836
ACTN2,Alpha-actinin-2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47653,-0.0136311136454837,0.0093113952037729,-0.0318814482448786,0.0046192209539112,0.143229724066742
ACTN2,Alpha-actinin-2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47653,0.00632393697138076,0.00904401186099763,-0.0114023262761746,0.0240502002189361,0.484408745662317
ACTN2,Alpha-actinin-2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47653,-0.01290629365226,0.0131390316218495,-0.038658795631085,0.012846208326565,0.325968701440127
ACTN2,Alpha-actinin-2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47653,-0.0163323196303714,0.0133623007013296,-0.0425224290049773,0.00985778974423458,0.221618204063944
ACTN2,Alpha-actinin-2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47653,0.00838591281014489,0.00998845616928117,-0.0111914612816462,0.027963286901936,0.401163314704667
ACTN2,Alpha-actinin-2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47653,-0.0295809778387223,0.0281267350598891,-0.084709378556105,0.0255474228786604,0.292946414085137
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,39969,0.0681254225279233,0.0101790671385083,0.0481744509364469,0.0880763941193996,2.26320175119377e-11
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,39969,-0.0413824065387947,0.0106976736389933,-0.0623498468712216,-0.0204149662063679,0.000110002927215043
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,39969,-0.0136245821261659,0.0127781365518073,-0.0386697297677083,0.0114205655153765,0.286330372946155
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,39970,0.0191918566802239,0.0175884773958899,-0.0152815590157203,0.053665272376168,0.275218461988434
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,39970,-0.0153020400712784,0.0113091435721415,-0.0374679614726757,0.00686388133011893,0.176052900142839
ACTN2,Alpha-actinin-2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47450,-0.0347600887084402,0.0102296790565152,-0.0548102596592099,-0.0147099177576705,0.000680013424971279
ACTN2,Alpha-actinin-2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47450,0.00862501502133652,0.00803154744521898,-0.00711681797129267,0.0243668480139657,0.282882047366747
ACTN2,Alpha-actinin-2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47450,0.0236297634049276,0.0095711770322543,0.00487025642170918,0.042389270388146,0.0135619811546137
ACTN2,Alpha-actinin-2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47450,0.0163355063875972,0.0149215491741232,-0.0129107299936843,0.0455817427688787,0.273633230197041
ACTN2,Alpha-actinin-2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47465,0.0199906416403776,0.00878907487080372,0.00276405489360233,0.0372172283871529,0.0229456186841707
ACTN2,Alpha-actinin-2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47465,0.126915420565082,0.0121811647639803,0.103040337627681,0.150790503502484,2.30537189875581e-25
ACTN2,Alpha-actinin-2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47541,0.0350816340935816,0.00930061450862948,0.0168524296566678,0.0533108385304953,0.000162358095421042
ACTN2,Alpha-actinin-2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47541,0.042652999009562,0.011526294392877,0.0200614619995231,0.0652445360196009,0.000215666150853246
ACTN2,Alpha-actinin-2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47541,0.0582912444019622,0.017093320527346,0.0247883361683641,0.0917941526355604,0.000650290794406943
ACTN2,Alpha-actinin-2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47541,0.0651471366547037,0.02035927647569,0.0252429547623513,0.105051318547056,0.00137668451386703
ACTN2,Alpha-actinin-2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47541,0.0306454667707581,0.0196249562775579,-0.00781944753325547,0.0691103810747717,0.118406001913372
ACTN2,Alpha-actinin-2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47541,0.0548974050997754,0.0286105440373435,-0.00117926121341791,0.110974071412969,0.05502389970908
ACTN2,Alpha-actinin-2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37288,-0.00474502948069915,0.00552486289699856,-0.0155737607588163,0.00608370179741802,0.39043851056461
ACTN2,Alpha-actinin-2,Physical activities,X864.Number of days or week walked 10+ minutes,47208,0.166621001364775,0.0201338703212093,0.127158615535204,0.206083387194345,1.34513380685085e-16
ACTN2,Alpha-actinin-2,Physical activities,X874.Duration of walks,44131,0.0322326181742437,0.00417091414335687,0.0240576264532643,0.0404076098952232,1.143634960349e-14
ACTN2,Alpha-actinin-2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46582,0.197666428382174,0.0189572986281069,0.160510123071084,0.234822733693264,2.13200571660389e-25
ACTN2,Alpha-actinin-2,Physical activities,X894.Duration of moderate activity,41463,0.161038835343505,0.0227618896199588,0.116425531688386,0.205652138998624,1.55145716936018e-12
ACTN2,Alpha-actinin-2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29097,0.0504590066660878,0.00828793637809405,0.0342146513650235,0.0667033619671522,1.22279701900415e-09
ACTN2,Alpha-actinin-2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46581,0.211953757013104,0.0194013075415523,0.173927194231661,0.249980319794546,1.02932504757226e-27
ACTN2,Alpha-actinin-2,Physical activities,X914.Duration of vigorous activity,37250,0.0352627129546794,0.00552122153381929,0.0244411187483936,0.0460843071609652,1.75036627242597e-10
